<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Immunol Immunother</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Immunol Immunother</journal-id><journal-title-group><journal-title>Cancer Immunology, Immunotherapy : CII</journal-title></journal-title-group><issn pub-type="ppub">0340-7004</issn><issn pub-type="epub">1432-0851</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40402283</article-id><article-id pub-id-type="pmc">PMC12098237</article-id>
<article-id pub-id-type="publisher-id">4069</article-id><article-id pub-id-type="doi">10.1007/s00262-025-04069-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eissa</surname><given-names>Maha Mohamed</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Allam</surname><given-names>Sonia Rifaat Ahmed</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ismail</surname><given-names>Cherine Adel</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ghazala</surname><given-names>Rasha Abdelmawla</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>El Skhawy</surname><given-names>Nahla</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ibrahim</surname><given-names>Eman Ibrahim El-said</given-names></name><address><email>eman.ibrahim1812@alexmed.edu.eg</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00mzz1w90</institution-id><institution-id institution-id-type="GRID">grid.7155.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2260 6941</institution-id><institution>Department of Medical Parasitology, Faculty of Medicine, </institution><institution>Alexandria University, </institution></institution-wrap>Al-Moassat Medical Campus, Alexandria, Egypt </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00mzz1w90</institution-id><institution-id institution-id-type="GRID">grid.7155.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2260 6941</institution-id><institution>Department of Clinical Pharmacology, Faculty of Medicine, </institution><institution>Alexandria University, </institution></institution-wrap>Alexandria, Egypt </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00mzz1w90</institution-id><institution-id institution-id-type="GRID">grid.7155.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2260 6941</institution-id><institution>Department of Medical Biochemistry, Faculty of Medicine, </institution><institution>Alexandria University, </institution></institution-wrap>Alexandria, Egypt </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2025</year></pub-date><volume>74</volume><issue>7</issue><elocation-id>212</elocation-id><history><date date-type="received"><day>27</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>26</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Cancer is one of the most dreaded diseases worldwide. Conventional treatments such as surgery, chemotherapy, and radiotherapy have limitations and adverse effects. Cancer immunotherapy and targeted therapies offer new treatment options. Parasite-based cancer therapy shows promise in fighting tumors. Some parasites have anti-cancer properties through multi-mechanistic strategies, with the molecular mimicry theory as a leading explanation for parasites&#x02019; anti-cancer effects. This study aimed to explore the existence of shared antigenic proteins between parasites (<italic>Trichinella spiralis</italic>, <italic>Schistosoma mansoni</italic>, and <italic>Toxoplasma gondii</italic>) and cancer cell lines (MCF-7&#x000a0;human breast cancer and A549 human lung cancer). Polyclonal antisera against <italic>T. spiralis</italic>, <italic>S. mansoni</italic>, and <italic>T. gondii</italic> parasites were generated in rabbits. Antibody&#x000a0;reactivity with extracts of MCF-7 and A549 cancer cells was detected using SDS-PAGE and immunoblotting. Results documented the molecular mimicry between parasites and cancers as it revealed cross-reactive bands when using <italic>T. spiralis</italic> antibodies against MCF-7 and A549 cancer cell extracts at approximate molecular weights of 70 and 35&#x000a0;kDa, and with <italic>S. mansoni</italic> antibodies at an approximate molecular weight of 80&#x000a0;kDa. <italic>Toxoplasma gondii</italic> antibodies neither reacted with MCF-7 human breast cancer nor A549 human lung cancer cell extracts. Results of this study could establish a foundation for subsequent investigation among a broad range of parasites for molecular mimicry with cancers. Identification, molecular characterization, and investigation of the anti-neoplastic activity of these cross-reactive antigens could shed light on new pathways for the potential development of a novel class of innovative cancer vaccine candidates and therapeutic antibodies of parasitic origin for cancer immunotherapy and targeted therapy.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Parasites</kwd><kwd>Cancer</kwd><kwd>Molecular mimicry</kwd><kwd>Cancer therapy</kwd></kwd-group><funding-group><award-group><funding-source><institution>Alexandria University</institution></funding-source></award-group><open-access><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par34">Cancer remains a major global health concern, despite global efforts in diagnosis and treatment. Ahead of World Cancer Day, the World Health Organization (WHO) in 2024 highlighted the growing global cancer burden. Lung cancer is the most commonly occurring cancer worldwide with 2.5 million new cases accounting for 12.4% of the total new cases. Regardless of the subtypes, it is considered the deadliest cancer with a 22% five-year survival rate. The second most common cancer is breast cancer with 2.3 million cases accounting for 11.6% of the total new cases. Breast cancer is highly heterogeneous in its pathological characteristics, with some cases showing a slow tumor growth rate with an excellent prognosis, while others are aggressive tumors [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par35">Surgery, radiotherapy, and chemotherapy are the most recommended and widely used policies in cancer treatment. Despite dramatic advances in conventional cancer policies, their application has significant adverse effects, and cost-effective concerns with limitations depending on tumor grade, stage, and patient tolerance [<xref ref-type="bibr" rid="CR2">2</xref>]. Chemotherapeutic drugs and radiation therapies also have various impacts on patients' cognitive function which is referred to as chemo-brain. In addition, chemoresistance continues to be a major problem in cancer therapy and is responsible for most relapses and poor survival outcomes in patients [<xref ref-type="bibr" rid="CR2">2</xref>]. Therefore, cancer research has focused on exploring innovative cancer treatments beyond these conventional methods.</p><p id="Par36">Immunotherapy and targeted therapy represent rapidly advancing therapies widely appreciated as groundbreaking in cancer treatment. Immunotherapy boosts patients&#x02019; immune response to fight cancer subsequently targeting and vigorously attacking cancer cells [<xref ref-type="bibr" rid="CR3">3</xref>]. Meanwhile, targeted therapy seeks to selectively affect cancer cells or the tumor microenvironment that promotes cancer growth. It focuses on specific cancerous molecules that are critical via suppressing cell migration, differentiation, and proliferation. Therefore, targeted therapy offers to minimize the off-target adverse effects [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par37">The main characteristics of cancer cells are their ability to deceive the immune system and create an immune-resistance tumor microenvironment. The defining hallmark of cancer cells is the expression of two main categories of antigens: tumor-associated antigens (TAAs) and tumor-specific antigens (TSAs). Tumor-associated antigens are overexpressed self-antigens and composed of differentiation antigens such as carcinoembryonic antigen, mucin-1 which is hypoglycosylated in adenocarcinomas, carbohydrate antigens (N-acetylgalactosamine O-serine/threonine (Tn), sialyl-Tn (STn), thymidine kinase (Tk) and Thomsen Friedenreich (TF)), <italic>p53</italic> suppressor gene and heat shock protein (HSP). Tumor-associated antigens have important roles in metastasis, cell adhesion, and invasion [<xref ref-type="bibr" rid="CR5">5</xref>]. Meanwhile, TSAs are strictly specific to tumor cells and responsible for cancer mutation. They arise mostly from oncogenic driver mutations that generate novel peptide sequences [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par38">The application of tumor-expressed antigens has emerged into the scientific consciousness for cancer immune therapy. However, autologous cancer vaccination strategies are insufficient to elicit a broad immune response. In addition, there is immune tolerance to self-antigens from cancer cells. These obstacles could be overcome by using xenogeneic orthologues antigens such as pathogens&#x02019; antigens [<xref ref-type="bibr" rid="CR7">7</xref>]. Pathogens, being foreign entities, can trigger a robust immune response, making them potential candidates for immunotherapy trials [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par39">The relationship between parasites and cancer has been a subject of scientific interest. Some parasites were confirmed as cancer inducers such <italic>as Schistosoma haematobium</italic> (<italic>S. haematobium</italic>), <italic>Clonorchis sinensis</italic> (<italic>C. sinensis</italic>), and <italic>Opisthorchis viverrini</italic> (<italic>O. viverrini</italic>). However, a negative correlation between other parasites and some cancer types has been documented [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par40">Parasite-based cancer therapy is dependent on multi-faceted mechanisms including induction of apoptosis, inhibition of angiogenesis, immunomodulation of tumor microenvironment, and molecular mimicry theory [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]</p><p id="Par41">The concept of shared cross-reactive antigens between parasites and cancer cells (molecular mimicry theory) glows as a sparkling concept that sounds noteworthy and deserves further investigation. Parasite-derived antigens, mainly glycoproteins, are highly immunogenic and reveal a high degree of homology with cancer antigens. For example, Tn antigen is expressed by different parasites such as <italic>Schistosoma mansoni</italic> (<italic>S. mansoni</italic>) and schistosomula, <italic>Echinococcus granulosus</italic> (<italic>E. granulosus</italic>) and its larval stage, and <italic>Trypanosoma cruzi</italic> (<italic>T. cruzi</italic>) [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Tk antigen is found in <italic>Taenia crassiceps</italic>, <italic>Mesocestoides vogae</italic> and <italic>Taenia hydatigena</italic> [<xref ref-type="bibr" rid="CR15">15</xref>]. Meanwhile, TF antigen is expressed by <italic>Fasciola hepatica</italic>, <italic>S. mansoni</italic>, and <italic>E. granulosus</italic> [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. STn antigen is expressed by <italic>E. granulosus</italic> and <italic>T. cruzi</italic> [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Surprisingly, <italic>T. cruzi</italic> antigens displayed common epitopes with mammalian mucins [<xref ref-type="bibr" rid="CR19">19</xref>]. In addition, N and O-linked glycans and the enzyme required for mucin-type O-glycosylation have been reported in <italic>Toxoplasma gondii</italic> (<italic>T. gondii</italic>) tachyzoites [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par42">Multiple experimental studies using parasites, their derived molecules and antisera demonstrated promising anti-cancerous activities against multiple cancer types. For instance, <italic>Plasmodium</italic> [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>], <italic>T. gondii</italic> [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>], <italic>Trypanosoma</italic> species (spp.) [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], <italic>Trichomonas vaginalis</italic> (<italic>T. vaginalis</italic>) [<xref ref-type="bibr" rid="CR29">29</xref>], <italic>E. granulosus</italic> [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], and <italic>Trichinella spiralis</italic> (<italic>T. spiralis</italic>) [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] have reported potent anti-cancerous efficacy against lung cancer.</p><p id="Par43">Regarding breast cancer, multiple research studies have explored the role of parasites in breast cancer therapy. For example, <italic>Plasmodium</italic> spp., [<xref ref-type="bibr" rid="CR34">34</xref>] <italic>T. gondii</italic>, [<xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>] <italic>Neospora caninum</italic> (<italic>N. caninum</italic>) [<xref ref-type="bibr" rid="CR38">38</xref>], <italic>Besnoitia jellisoni</italic> (<italic>B. jellisoni</italic>) [<xref ref-type="bibr" rid="CR39">39</xref>], <italic>T. cruzi</italic> [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], and <italic>Leishmania</italic> [<xref ref-type="bibr" rid="CR42">42</xref>] are among the suggested protozoa in treating breast cancer. Meanwhile, <italic>E. granulosus</italic> [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>], <italic>Taenia solium</italic> [<xref ref-type="bibr" rid="CR46">46</xref>], and <italic>T. spiralis</italic> [<xref ref-type="bibr" rid="CR47">47</xref>] are examples of helminths that have been reported to have anti-neoplastic effects against breast cancer. Interestingly, <italic>S. mansoni</italic>, which expresses human cancer-associated antigens Tn and TF, was recently reported by the current authors to exhibit anti-neoplastic activity against breast cancer in a pre-clinical study [<xref ref-type="bibr" rid="CR48">48</xref>].</p><p id="Par44">In this study, our goal was to explore molecular mimicry between parasites and cancers by investigating the presence of cross-reactive antigens between parasites (<italic>T. spiralis</italic>, <italic>S. mansoni</italic>, and <italic>T. gondii</italic>) and cancer cells (MCF-7 human breast and A549 human lung cancer cell lines.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Maintenance of parasites life cycles and antigens preparations</title><p id="Par45">Parasitic antigens were prepared from the infective stage of the following parasites: <italic>T. spiralis</italic> (larvae), <italic>S. mansoni</italic> (cercariae), and <italic>T. gondii</italic> (tachyzoites). The life cycles of these parasites were maintained at the laboratory of the Medical Parasitology Department, Faculty of Medicine, Alexandria University, Egypt.</p></sec><sec id="Sec4"><title>Autoclaved <italic>Trichinella spiralis</italic> larval antigen (A<italic>Ts</italic>A)</title><p id="Par46"><italic>Trichinella spiralis</italic> life cycle was maintained by serial passages in adult Wistar rats. The larvae were collected from infected rats by the digestion method and were washed five times in phosphate buffer saline (PBS) at 1000&#x000a0;rpm for 10&#x000a0;min [<xref ref-type="bibr" rid="CR49">49</xref>]. The final pellet was resuspended in PBS into a screw-capped vial, autoclaved under the pressure of 15 Ib at 121&#x000a0;&#x000b0;C for 15&#x000a0;min, and stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C until later use [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec><sec id="Sec5"><title>Autoclaved <italic>Schistosoma mansoni</italic> cercarial antigen (A<italic>Sm</italic>A)</title><p id="Par47"><italic>Schistosoma mansoni</italic> life cycle was maintained by passage through <italic>Biomphalaria alexandrina</italic> snails and Swiss albino mice [<xref ref-type="bibr" rid="CR51">51</xref>]. <italic>S. mansoni</italic> cercariae were shed from snails, gravity-sedimented for two hours at 4&#x000a0;&#x000b0;C, excess fluid removed, and the pellet was resuspended in PBS into a screw-capped vial, autoclaved under the pressure of 15 Ib at 121&#x000a0;&#x000b0;C for 15&#x000a0;min, and stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C until later use [<xref ref-type="bibr" rid="CR52">52</xref>].</p></sec><sec id="Sec6"><title>Autoclaved <italic>Toxoplasma gondii</italic> tachyzoites antigen (A<italic>Tg</italic>A)</title><p id="Par48"><italic>Toxoplasma gondii</italic> (virulent RH HXGPRT (&#x02212;) strain) life cycle was maintained through serial intraperitoneal passages of tachyzoites in Swiss albino mice [<xref ref-type="bibr" rid="CR53">53</xref>]. The freshly collected tachyzoites were centrifuged at 500&#x000a0;rpm for five minutes to allow sedimentation of leukocytes and heavier particles. The supernatant was then collected and washed three times at 2000&#x000a0;rpm for five minutes. The final pellet was resuspended in PBS into a screw-capped vial, autoclaved under the pressure of 15 Ib at 121&#x000a0;&#x000b0;C for 15&#x000a0;min, and stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C until later use [<xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec7"><title>Preparation of hyperimmune antisera</title><sec id="Sec8"><title>Preparation of antisera against A<italic>Ts</italic>A</title><p id="Par49">Male New Zealand albino rabbit (2.5&#x000a0;kg) was immunized by intramuscular injection of 300&#x000a0;&#x003bc;g of A<italic>Ts</italic>A emulsified in Freund's complete adjuvant (FCA). Two booster doses of the antigen emulsified in an equal volume of FCA were injected subcutaneously at two-week intervals. Blood samples were collected four days after the last injection. The serum was separated from the collected blood via centrifugation at 2000&#x000a0;rpm for 15&#x000a0;min then stored at -20&#x000a0;&#x000b0;C for later use [<xref ref-type="bibr" rid="CR54">54</xref>].</p></sec><sec id="Sec9"><title>Preparation of antisera against A<italic>Sm</italic>A</title><p id="Par50">Male New Zealand albino rabbit (2.5&#x000a0;kg) was immunized with 5&#x000a0;mg of A<italic>Sm</italic>A in FCA. The antigen was emulsified in an equal volume of adjuvant and the rabbit was injected intramuscularly once a week for six weeks. Blood samples were collected one week after the last injection. The serum was separated from the collected blood via centrifugation at 2000&#x000a0;rpm for 15&#x000a0;min, then stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C for later use [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>].</p></sec><sec id="Sec10"><title>Preparation of antisera against A<italic>Tg</italic>A</title><p id="Par51">Male New Zealand albino rabbit (2.5&#x000a0;kg) was immunized by subcutaneous injection of 0.5&#x000a0;mg of A<italic>Tg</italic>A emulsified in an equal volume of FCA. Three booster doses of the antigen emulsified in an equal volume of FCA were injected; the first dose was injected two weeks after the priming dose. In the meantime, the second and third booster doses were injected after one week with a one-week interval. Blood samples were collected one week after the last injection. The serum was separated from the collected blood via centrifugation at 2000&#x000a0;rpm for 15&#x000a0;min, then stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C for later use [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par52">For confirmation of the positivity of parasite IgG antibodies in rabbits&#x02019; antisera, an enzyme-linked immunoassay (ELISA) reaction was performed separately for each antiserum using its corresponding antigen. In brief, ninety-six-well plates were coated with the parasitic antigens diluted 1:20 with carbonate buffer (100&#x000a0;&#x003bc;l/ well) (A<italic>Sm</italic>A, A<italic>Ts</italic>A and A<italic>Tg</italic>A). Following overnight incubation at 4&#x000a0;&#x000b0;C, blocking buffer (1% bovine albumin) was added to the plates (200&#x000a0;&#x003bc;l/ well) for two hours at room temperature, then washed with sodium chloride buffer containing 0.05% Tween 20. One hundred &#x003bc;l of the prepared antisera diluted in blocking buffer was added to its corresponding antigen and incubated at 37&#x000a0;&#x000b0;C for two hours. The plates were then washed four times with PBS. One hundred &#x003bc;l of diluted&#x000a0;secondary antibody (goat anti-rabbit; Sigma-Aldrich) in blocking buffer was added and incubated at 37&#x000a0;&#x000b0;C for one hour. Finally, following washing, the plates were incubated with the chromogenic substrate and the optical densities of the wells were read at 450&#x000a0;nm using an ELISA reader (BIO-RAD). Serum from a non-immunized rabbit was used as a negative control [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>].</p></sec><sec id="Sec11"><title>Preparation of cancer cell line lysates</title><p id="Par53">MCF-7 human breast cancer and A549 lung cancer cell pellets (7&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells) were purchased from the Center of Excellence for Research in Regenerative Medicine and its Applications, Faculty of Medicine, Alexandria University. MCF-7 and A549 cell pellets were washed twice with PBS and resuspended in modified radioimmunoprecipitation assay buffer (RIPA) lysis and extraction buffer containing a cocktail of protease inhibitors (Thermo Fisher Scientific) for 15&#x000a0;min on ice. Cell extracts were centrifuged for 10&#x000a0;min at 14,000&#x000a0;rpm to pellet cell debris. Supernatants were collected and stored at &#x02212;&#x02009;20&#x000a0;&#x000b0;C until later use [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p></sec></sec><sec id="Sec12"><title>Comparative immunoproteomic analysis between autoclaved parasitic antigens and extracts of MCF-7 and A549 cancer cells</title><sec id="Sec13"><title>One-dimensional sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE)</title><p id="Par54">Sodium dodecyl polyacrylamide gel electrophoresis was conducted for extracts of MCF-7, A549 cancer cells, and parasitic antigens A<italic>Ts</italic>A, A<italic>Sm</italic>A, and A<italic>Tg</italic>A. The protein concentration of each sample was assessed using a NanoDrop&#x02122; 2000 spectrophotometer and was expressed in mg/ml. BLUeye Prestained Protein Ladder (BIO-HELIX) and samples were allowed to run using an 8% stacking gel followed by 12% resolving gel (Tris&#x02013;HCl PH:8.8). Gel was stained with Commasie Brilliant Blue R 250 (Sigma-Aldrich), documented using Gel Doc&#x02122; XR&#x02009;+&#x02009;(BIO-RAD) documentation system and analyzed by Image Lab software 5.1 (BIO-RAD) [<xref ref-type="bibr" rid="CR61">61</xref>].</p></sec><sec id="Sec14"><title>Immunoblotting and immunodetection</title><p id="Par55">Three separate SDS-PAGE gels; MCF-7, A549 and A<italic>Ts</italic>A; MCF-7, A549 and A<italic>Tg</italic>A and MCF-7, A549 and A<italic>Sm</italic>A were electrophoresed. Then, each SDS-PAGE-separated proteins were transferred to nitrocellulose membranes and probed with the corresponding rabbit antisera diluted 1:100 in Tris-buffered saline with 0.5% v/v Tween 20 (TBST) overnight at 4&#x000a0;&#x000b0;C as the primary antibody, followed by two hours at room temperature in a solution of horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG antibodies (Sigma-Aldrich) diluted 1:1000 in TBST as the secondary antibody. Finally, it was washed, and chemiluminescent detection was performed. It was documented using Gel Doc&#x02122; XR&#x02009;+&#x02009;(BIO-RAD) documentation system and analyzed by Image Lab software 5.1 (BIO-RAD) [<xref ref-type="bibr" rid="CR62">62</xref>]. At least three replicates of SDS-PAGE gels and immunoblots have been done for cross-reactive experiments.</p></sec></sec></sec><sec id="Sec15"><title>Results</title><sec id="Sec16"><title>SDS-PAGE analysis</title><p id="Par56">To test the molecular mimicry theory, SDS-PAGE was conducted. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> demonstrate the data analysis for the SDS-PAGE lanes profile showing molecular weight ranges for cell extracts of MCF-7 human breast cancer, A549 human lung cancer, and parasitic antigens (A<italic>Ts</italic>A, A<italic>Tg</italic>A, and A<italic>Sm</italic>A). For MCF-7 human breast cancer, the molecular weights of protein bands ranged approximately from 180 to 11&#x000a0;kDa (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Lane 2); meanwhile, for A549 human lung cancer, the molecular weights of protein bands ranged from approximately 200&#x02013;11&#x000a0;kDa (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Lane 3). As regards parasitic antigens, the molecular weights of protein bands of A<italic>Ts</italic>A ranged from approximately 75&#x02013;11&#x000a0;kDa (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Lane 4), of A<italic>Tg</italic>A ranged from approximately 70&#x02013;11&#x000a0;kDa (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Lane 5), and of A<italic>Sm</italic>A ranged from approximately 135&#x02013;12&#x000a0;kDa (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Lane 7).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Sodium dodecyl polyacrylamide gel electrophoresis of cell extracts of MCF-7 human breast cancer, A549 human lung cancer and parasitic antigens (A<italic>Ts</italic>A, A<italic>Tg</italic>A and A<italic>Sm</italic>A). Lane 1: BLUeye Prestained Protein Ladder electrophoretic pattern, lane 2: MCF-7 human breast cancer cell extracts electrophoretic pattern, lane 3: A549 human lung cancer cell extract electrophoretic pattern, lane 4: A<italic>Ts</italic>A electrophoretic pattern, lane 5: A<italic>Tg</italic>A electrophoretic pattern, lane 6: electrophoretic pattern of external antigen and lane 7: A<italic>Sm</italic>A electrophoretic pattern. A<italic>Ts</italic>A: autoclaved <italic>T. spiralis</italic> antigen; A<italic>Tg</italic>A: autoclaved <italic>T. gondii</italic> antigen; A<italic>Sm</italic>A: autoclaved <italic>S. mansoni</italic> antigen. Std: Standard</p></caption><graphic xlink:href="262_2025_4069_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Data analysis for SDS-PAGE lanes profile showing molecular weight ranges for cells extracts of MCF-7 human breast cancer cell extracts, A549 human lung cancer cell extracts, and parasitic antigens (A<italic>Ts</italic>A, A<italic>Tg</italic>A, and A<italic>Sm</italic>A)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Lanes</th><th align="left">Molecular weights range in kDa</th></tr></thead><tbody><tr><td align="left">Lane 1: Standard protein marker</td><td align="left">245&#x02013;11</td></tr><tr><td align="left">Lane 2: MCF-7 cell extracts</td><td align="left">180&#x02013;11</td></tr><tr><td align="left">Lane 3: A549 cell extracts</td><td align="left">200&#x02013;11</td></tr><tr><td align="left">Lane 4: A<italic>Ts</italic>A</td><td align="left">75&#x02013;11</td></tr><tr><td align="left">Lane 5: A<italic>Tg</italic>A</td><td align="left">70&#x02013;11</td></tr><tr><td align="left">Lane 7: A<italic>Sm</italic>A</td><td align="left">135&#x02013;12</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Immunoblotting detection</title><p id="Par57">The reactivity of prepared polyclonal sera was confirmed using ELISA. Immunoblotting analysis was performed to verify the presence of cross-reactive antigens between cell extracts of MCF-7 and A549 cancer cells and parasitic antigens against their corresponding polyclonal antibodies. Upon incubation with anti-<italic>T. spiralis</italic> antibodies, two prominent bands corresponding to approximately 70 and 35&#x000a0;kDa were consistently detected in A<italic>Ts</italic>A and both MCF-7 human breast cancer and A549 human lung cancer cell extracts (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A). When applying anti-<italic>S. mansoni</italic> antibodies, a prominent band corresponding to approximately 80&#x000a0;kDa was consistently detected in A<italic>Sm</italic>A and both MCF-7 human breast cancer and A549 human lung cancer cell extracts (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B). Interestingly, when using anti-<italic>T. gondii</italic> antibodies, no cross-reactive bands were detected in both MCF-7 human breast cancer and A549 human lung cancer cell extracts (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). However, only two reactive bands were detected in A<italic>Tg</italic>A at approximately 30 and 13&#x000a0;kDa.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Immunoblotting analysis of cell extracts of MCF-7 human breast cancer, A549 human lung cancer and parasitic antigens (A<italic>Ts</italic>A, A<italic>Tg</italic>A and A<italic>Sm</italic>A). <bold>A</bold> After incubation with anti-A<italic>Ts</italic>A antibodies; lane 1: protein molecular weight marker, lane 2: MCF-7 human breast cancer cell extract, lane 3: A549 human lung cancer cell extract and lane 4: A<italic>Ts</italic>A. <bold>B</bold> After incubation with anti-A<italic>Sm</italic>A antibodies; lane 1: protein molecular weight marker, lane 2: MCF-7 human breast cancer cell extract, lane 3: A549 human lung cancer cell extract and lanes 4, 5 &#x00026; 6: A<italic>Sm</italic>A. <bold>C</bold> After incubation with anti-A<italic>Tg</italic>A antibodies; lane 1: protein molecular weight marker, lane 2: MCF-7 human breast cancer cell extract, lane 3: A549 human lung cancer cell extract and lane 4: A<italic>Tg</italic>A. Red arrow points out the shared cross-reactive bands. A<italic>Ts</italic>A: autoclaved <italic>T. spiralis</italic> antigen; A<italic>Tg</italic>A: autoclaved <italic>T. gondii</italic> antigen; A<italic>Sm</italic>A: autoclaved <italic>S. mansoni</italic> antigen. Std: Standard</p></caption><graphic xlink:href="262_2025_4069_Fig2_HTML" id="MO2"/></fig></p><p id="Par58">Based on the aforementioned results, the presence of cross-reactive antigens between MCF-7 human breast cancer and A549 human lung cancer cell extracts was detected after incubation with anti-<italic>T. spiralis</italic> antibodies at approximately molecular weights 70 and 35&#x000a0;kDa and anti-<italic>S. mansoni</italic> at 80&#x000a0;kDa. Meanwhile, no cross-reactive antigens were detected after incubation with anti-<italic>T. gondii</italic> antibodies.</p></sec></sec><sec id="Sec18"><title>Discussion</title><p id="Par59">Cytotoxic agent-based chemotherapy has been the main strategy for the treatment of a wide range of cancers for decades. Most of these chemotherapeutic agents show severe adverse effects due to a non-specific impact on normal healthy cells. To address this issue, immunotherapy and targeted therapy have significantly advanced cancer therapeutic strategies [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par60">Cancer immunotherapy encompasses several promising strategies such as cancer vaccines, antibody-based therapies, adoptive cell transfer, viral-based therapies, checkpoint inhibitors, and cytokines [<xref ref-type="bibr" rid="CR64">64</xref>]. While monoclonal antibodies and small molecule inhibitors are common targeted therapies [<xref ref-type="bibr" rid="CR4">4</xref>]. For example, trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor-2 (HER-2) is approved by the Food and Drug Administration (FDA) as a first-line treatment of HER-2-positive cancer [<xref ref-type="bibr" rid="CR65">65</xref>]. Similarly, pembrolizumab, an FDA-approved monoclonal antibody targets programmed cell death-1 (PD-1) protein and is effective against breast, lung, gastric, and melanoma cancers [<xref ref-type="bibr" rid="CR66">66</xref>]. Antibody&#x02013;drug conjugates and bispecific antibodies are innovative approaches in antibody-based cancer therapies [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. In addition, bortezomib, a proteasome inhibitor, has been approved for treating multiple myeloma and mantle cell lymphoma [<xref ref-type="bibr" rid="CR69">69</xref>].</p><p id="Par61">Parasite-based cancer therapeutics hold considerable promising implications in the oncology field. Parasites can be utilized for cancer immunotherapy by providing highly immunogenic cancer vaccine candidates [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>], acting as immunomodulators [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>], adjuvants [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR74">74</xref>], and inhibitors of nuclear factor kappa B (NF-&#x003ba;B) [<xref ref-type="bibr" rid="CR26">26</xref>]. Additionally, they could be used as oncolytic agents [<xref ref-type="bibr" rid="CR75">75</xref>] and for developing therapeutic monoclonal/polyclonal antibodies [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR77">77</xref>], for targeted cancer therapy, as they can selectively attack cancer cells, leading to their destruction through antibody-dependent cell cytotoxicity (ADCC) while sparing healthy ones [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par62">The molecular mimicry theory, among others, has been postulated to be the chief mechanism behind parasites&#x02019; anti-neoplastic activity. This was verified by the unique selectivity of certain parasites against specific types of cancers. For instance, Eissa et al. (2019) demonstrated that although both <italic>S. mansoni</italic> and <italic>T. spiralis</italic> antigens induced potent immunomodulatory potential in a murine model of colon cancer, yet anti-neoplastic activity was only demonstrated for <italic>S. mansoni</italic> [<xref ref-type="bibr" rid="CR52">52</xref>]. This was explained by the shared antigens between the <italic>Schistosoma</italic> parasite and cancer, as human cancer-associated antigens Tn and TF were reported to be expressed by <italic>S. mansoni</italic> parasite and its schistosomula [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Such findings have highlighted the molecular mimicry theory between parasites and cancer cells as a research hotspot. In this view, the present study investigated the presence of molecular mimicry and cross-reactive antigens between MCF-7 human breast and A549 lung cancer cells and parasites like <italic>T. spiralis</italic>, <italic>T. gondii</italic> and <italic>S. mansoni</italic>.</p><p id="Par63">In the current study, immunoproteomic profiling showed different specific bands for each parasite and each cancer cell. Hyperimmune sera from immunized rabbits against each parasite were used to detect cross-reactivity between each parasite&#x02019;s antigen and each cancer cell extract. Results showed that MCF-7 and A549 cancer cell extracts shared two antigens with A<italic>Ts</italic>A at molecular weights of approximately 70 and 35&#x000a0;kDa. In alignment, several studies have demonstrated cross-reactive antigens between <italic>T. spiralis</italic> and various cancer types, including Lewis lung (LL) cancer, myeloma, and osteosarcoma [<xref ref-type="bibr" rid="CR79">79</xref>&#x02013;<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par64">For example, a fully human single-chain antibody (ScFv) raised against <italic>T. spiralis</italic> 7 trans-membrane receptors (Ts7TMR) bound specifically to A549 lung cancer cells [<xref ref-type="bibr" rid="CR82">82</xref>]. Furthermore, this antibody inhibited lung cancer growth in both <italic>in vitro</italic> and <italic>in vivo</italic> experiments [<xref ref-type="bibr" rid="CR33">33</xref>]. <italic>Trichinella spiralis</italic> small heat shock protein (sHSP-DQ 986457) was identified as a gene associated with LL cancer, demonstrating cross-reactivity with LL cancer antisera [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par65">In another study, a 33&#x000a0;kDa&#x000a0;<italic>T. spiralis</italic> antigen showed a reaction with anti- Sp2/0 myeloma cells, with tropomyosin being a significant component of myeloma-associated antigens. Immunization with tropomyosin and crude <italic>T. spiralis</italic> antigen resulted in a similar antitumor effect in <italic>in vivo</italic> testing indicating its important role in eliciting cross-protective immunity [<xref ref-type="bibr" rid="CR79">79</xref>]. Furthermore, a <italic>T. spiralis</italic> cDNA expression library demonstrated cross-reactivity with Sp2/0 myeloma antisera at approximately 15.6&#x000a0;kDa, the TS2 antigen gene, with six predicted cross-reactive epitopes [<xref ref-type="bibr" rid="CR80">80</xref>]. In the SP2/0 myeloma mice model infected with <italic>T. spiralis,</italic> genes encoding RpL41, NKTR, Rbbp4, and ANXA2 were enriched in tumor cells, suggesting a potential role in tumor growth inhibition [<xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par66">Additionally, cross-reactive antigens were detected between <italic>T. spiralis</italic> and osteosarcoma, where seven cross-antigen genes between cDNA expression library of muscle larvae and anti-MG-63 osteosarcoma cells antisera were found. Among these antigens, (X/7M_003375331.1) which encodes tumor protein D52 (TPD52), was found to have the highest hydrophilicity with a predicted score of 0.7106 indicating that this protein may be the most protective among the seven detected genes. Anti-TPD52 demonstrated significant anti-cancer activity against osteosarcoma in both <italic>in vitro</italic> and <italic>in vivo</italic> experiments, outperforming anti-<italic>T. spiralis</italic> antiserum in boosting immunity without causing histopathological damage [<xref ref-type="bibr" rid="CR77">77</xref>].</p><p id="Par67">In the present study, anti-A<italic>Sm</italic>A antibodies cross-reacted with both MCF-7 human breast and A549 cancer cell extracts at a molecular weight of approximately 80&#x000a0;kDa. Previous research in 2006 showed that sera from <italic>S. mansoni</italic> infected mice reacted with human gastric adenocarcinoma and bladder carcinoma cell lines [<xref ref-type="bibr" rid="CR17">17</xref>]. To the best of our knowledge, this is the first report to demonstrate shared antigens between <italic>S. mansoni</italic> and cancer cells. These findings support the anti-neoplastic activity of A<italic>Sm</italic>A against breast cancer in a pre-clinical study [<xref ref-type="bibr" rid="CR48">48</xref>] and other types of cancer such as colon cancer [<xref ref-type="bibr" rid="CR52">52</xref>], sarcoma, [<xref ref-type="bibr" rid="CR84">84</xref>] and histiocytoma [<xref ref-type="bibr" rid="CR85">85</xref>]. This suggests the potential of <italic>S. mansoni</italic> antigens as a promising candidate for cancer immunotherapy.</p><p id="Par68"><italic>Toxoplasma gondii</italic> has been the focus of many experimental studies and displayed potent anti-neoplastic activity against breast cancer [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and lung cancer [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The postulated mechanisms were mainly hypothesized through their immunomodulatory mechanism, direct invasion, and cytotoxic effect on cancer cells [<xref ref-type="bibr" rid="CR86">86</xref>]. The molecular mimicry theory has been a lightly touched topic as regards <italic>Toxoplasma</italic> and breast /lung cancer.</p><p id="Par69">Interestingly, in the current study, anti-A<italic>Tg</italic>A antibodies did not react with MCF-7 human breast or human lung cancer cell extracts. Our results concerning MCF-7 human breast cancer cells align with those of El Skhawy, 2022, who demonstrated the absence of cross-reactivity between A<italic>Tg</italic>A and MCF-7 human breast cancer cell extracts, while in the same study, four cross-reactive bands were detected with Ehrlich carcinoma, a murine mammary carcinoma, using similar parameters to our current study at an approximate molecular weights of 60, 26, 22 and 12.5&#x000a0;kDa [<xref ref-type="bibr" rid="CR87">87</xref>]. This justified the potent anti-neoplastic activity of A<italic>Tg</italic>A against Ehrlich solid carcinoma observed in both prophylactic and therapeutic experiments [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Remarkably, our results for the absence of <italic>Toxoplasma</italic> cross-reactivity with MCF-7 breast cancer cells are controversial with those published in the literature. This may be related to the differences in experimental parameters used in the different studies such as the strain of <italic>Toxoplasma</italic>, the type of antigen, the source of antisera (rabbit <italic>vs</italic> human), the type of cancer cell line (human <italic>vs</italic> murine), the form of cancer cell (intact cells <italic>vs</italic> cell extract), and the detection technique employed. For example, Mohamadi et al. (2019) used <italic>T. gondii</italic> lysate antigen and the (4T1) murine cancer cell line. They postulated shared antigens between <italic>Toxoplasma</italic> and murine intact breast cancer cells via the binding of <italic>Toxoplasma</italic> antibodies on the surface of breast cancer cells using flow cytometry [<xref ref-type="bibr" rid="CR58">58</xref>]. Additionally, Hosseini et al. (2023) used human sera from <italic>Toxoplasma</italic>-positive patients and examined both MCF-7 human breast cancer and 4T1 murine breast cancer cell extracts [<xref ref-type="bibr" rid="CR88">88</xref>]. However, our results do not suggest disregarding the potential anti-neoplastic role of <italic>Toxoplasma</italic> as a plethora of experimental studies have demonstrated the potent anti-neoplastic activity of <italic>Toxoplasma</italic> in nearly all experimental cancer models investigated to date [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. The <italic>Toxoplasma</italic> parasite has been found to induce anti-cancer activity through different mechanistic strategies such as the induction of apoptosis [<xref ref-type="bibr" rid="CR90">90</xref>&#x02013;<xref ref-type="bibr" rid="CR92">92</xref>], anti-tumor immune response [<xref ref-type="bibr" rid="CR93">93</xref>], smart targeting of the tumor microenvironment [<xref ref-type="bibr" rid="CR93">93</xref>&#x02013;<xref ref-type="bibr" rid="CR96">96</xref>], and anti-angiogenesis [<xref ref-type="bibr" rid="CR25">25</xref>]. Other studies demonstrated that dense granule 16<italic>-</italic>derived from <italic>T. gondii</italic> enhanced the anti-neoplastic efficacy of irinotecan against non-small-cell lung carcinoma cells, by inhibiting the NF-&#x0049b;B activation [<xref ref-type="bibr" rid="CR26">26</xref>]. Additionally, <italic>T. gondii</italic> profilin-like protein showed a marked auxiliary role as an adjuvant with the autologous whole-tumor-cell vaccine against colon cancer [<xref ref-type="bibr" rid="CR97">97</xref>]. Interestingly, the combination therapy of <italic>T. gondii</italic>- deficient dense granule 17 and anti-PD-&#x000a0;1 antibody elicited a significant anti-tumor immune response with a synergic effect against melanomas [<xref ref-type="bibr" rid="CR98">98</xref>]. In future studies, researchers should further explore the diverse mechanisms of <italic>Toxoplasma&#x02019;s</italic> anti-neoplastic activity and consider parameter variations to gain a comprehensive understanding of its potential in cancer treatment.</p><p id="Par70">In addition to our findings, several studies have reported molecular mimicry between parasites such as <italic>E. granulosus, Setaria equina</italic> (<italic>S. equina</italic>), and <italic>T. cruzi,</italic> and certain cancer types. <italic>E. granulosus</italic>, the dog tapeworm, and its derived antigens and antisera have demonstrated potent anti-neoplastic activity in several studies. The parasite and its larval stage, hydatid cyst, are rich in glycosylated antigens such as Tn, Sial Tn [<xref ref-type="bibr" rid="CR13">13</xref>], and TF [<xref ref-type="bibr" rid="CR16">16</xref>] antigens which are prominent TAAs. Studies have also demonstrated the anti-cancerous activity of <italic>E. granulosus</italic> against; breast cancer [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR99">99</xref>], colorectal, [<xref ref-type="bibr" rid="CR100">100</xref>] lung, [<xref ref-type="bibr" rid="CR31">31</xref>] and bone cancers [<xref ref-type="bibr" rid="CR101">101</xref>].</p><p id="Par71">In breast cancer, antisera raised against hydatid cyst antigens reacted with 4T1 breast cancer cells [<xref ref-type="bibr" rid="CR102">102</xref>&#x02013;<xref ref-type="bibr" rid="CR104">104</xref>]. Similarly, breast cancer patients&#x02019; sera showed cross-reactivity with ~ 27/28&#x000a0;kDa derived from hydatid cyst wall antigens [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. In addition, ~&#x02009;40&#x000a0;kDa bands derived from hydatid cyst fluid interacted with breast cancer patients&#x02019; sera [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. Interestingly, prophylactic immunization with this ~&#x02009;27/28&#x000a0;kDa protein demonstrated significant anti-neoplastic activity in a breast cancer murine model [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR107">107</xref>].</p><p id="Par72">In lung cancer, an earlier study in 1979 reported possible antigenic similarity between pulmonary carcinoma and cysts of <italic>E. granulosus.</italic> A broad and intense band was observed in an immunoelectrophoretic test between serum from a patient with pulmonary carcinoma and hydatid cyst fluid [<xref ref-type="bibr" rid="CR108">108</xref>]. Notably, Berriel et al. (2021) supported the anti-neoplastic potential of <italic>E. granulosus</italic> against lung cancer. They reported that anti-hydatid cyst fluid antibodies recognized membrane and intracellular molecules in LL/2 cancer. In addition, hydatid cyst fluid immunization showed a protective effect against LL/2 lung cancer in murine model [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par73">In colorectal cancer, anti-hydatid cyst fluid antibodies identified cell surface and intracellular antigens in CT26 colon cancer cells and cross-reacted with five protein spots of CT26 colon cancer proteins. These proteins were analyzed by MALDI TOF/TOF&#x02013;MS, and two of them were identified as mortalin and creatine kinase M-type. Although no significant homology between creatine kinase M-type and <italic>E. granulosus</italic> proteins was found, interestingly, colon cancer cells (CT26) mortalin showed 60% homology with <italic>E. granulosus</italic> HSP-70 potentially justifying the anti-cancer properties of <italic>E. granulosus</italic> in a mouse model of colorectal cancer [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. In bone cancer, hydatid cyst wall antigens cross-reacted with sera from patients with bone cancers at 70 and 53&#x000a0;kDa [<xref ref-type="bibr" rid="CR101">101</xref>].</p><p id="Par74"><italic>Setaria equina</italic> is a common vector-borne parasite of equines worldwide. Adult worms are primarily found in the peritoneal cavity of horses and donkeys [<xref ref-type="bibr" rid="CR110">110</xref>]. Abdel-Latif and Sakran (2016) explored the molecular mimicry between this nematode parasite and certain cancers. They identified cross-reactivity between anti-<italic>Setaria equina</italic> antibodies and cell extracts from Huh-7 hepatoma and MCF-7 human breast cancer cells at 75 and 70&#x000a0;kDa, potentially corresponding to Glucose-6-phosphate dehydrogenase and HSP-70, respectively [<xref ref-type="bibr" rid="CR111">111</xref>]. These shared antigens may explain the anti-cancer effects of <italic>S. equina</italic> excretory&#x02013;secretory products against hepatocellular carcinoma in a rat model [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR113">113</xref>].</p><p id="Par75"><italic>Trypanosoma cruzi,</italic> a parasite causing Chagas' disease in humans, has shown anti-cancer properties against various types of cancer in both <italic>in vitro</italic> and <italic>in vivo</italic> experiments [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Zenina et al. (2008) demonstrated that antigens in <italic>T. cruzi</italic> with anti-cancer activity have common epitopes with mammalian mucins. Immunization of mice with type II and III mucins shared antigens of <italic>T. cruzi</italic> inhibited the Ehrlich adenocarcinoma growth and induced onco-protective effects [<xref ref-type="bibr" rid="CR41">41</xref>]. In addition, anti- <italic>T. cruzi</italic> antibodies showed anti-cancerous efficacy against mammary carcinoma [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. Notably, anti-<italic>T. cruzi</italic> antibodies specifically recognize human colon cancer cell lines (HT29 and LS-174&#x000a0;T) and breast cancer cell lines (T47D and MCF-7) [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par76">Remarkably, anti-<italic>T. cruzi</italic> antibodies have been found to recognize and cross-react with membrane and intracellular molecules in lung cancer cells. Immunization of mice bearing lung cancer with <italic>T. cruzi</italic> lysate showed potent reduction in tumor size and increase in survival rates [<xref ref-type="bibr" rid="CR28">28</xref>]. Regarding hematologic cancer, polyclonal anti- <italic>T. cruzi</italic> antibodies cross-reacted with acute lymphoblastic leukemia SUPB15 cell line. A prominent band of approximately to 100 kDa protein was consistently detected and was identified as nucleolin protein [<xref ref-type="bibr" rid="CR76">76</xref>]. In addition, a previous study found that polyclonal anti- <italic>T. cruzi</italic> antibodies species specific cross-reacted in multiple bands with acute lymphoblastic leukemia cells (95, 75, 70, 55, 50, and 43 kDa) and neuroblastoma (140, 90, 85, 80, 70, and 55 kDa) [<xref ref-type="bibr" rid="CR116">116</xref>].</p><p id="Par77">From the aforementioned data, it is evident that epitope homology and cross-reactivity between parasites and cancer cells are potent explanations for understanding the mechanisms involved in the anti-cancer activities of a wide range of parasites. Administration of parasitic antigens could flare up the immune response to eradicate parasites and simultaneously, homologous malignant cells [<xref ref-type="bibr" rid="CR10">10</xref>]. Thereby, they could directly raise innate, humoral, and cell-mediated cytotoxic immunity against cancers; they might enable cross-reactive T cells to recognize and kill tumor cells via molecular mimicry [<xref ref-type="bibr" rid="CR117">117</xref>]. In addition, polyclonal antibodies against these shared antigens can mediate ADCC targeting tumor cells for destruction, promotion of antigen presentation and induction of anti-tumor responses [<xref ref-type="bibr" rid="CR118">118</xref>]. Thus, the results of this study could establish a foundation for subsequent investigation among a broad range of parasites and different types of cancer. A systematic exploration of parasites could illuminate new pathways for potentially discovering a novel class of innovative cancer vaccine candidates and therapeutic antibodies of parasitic origin, among others, for cancer therapy. Interdisciplinary collaboration among researchers from different scientific disciplines, funding agencies, the pharmaceutical industry, along with modern technology, is crucial for overcoming challenges in identifying shared antigenic components between parasites and cancers, understanding mechanisms of action, advancing to clinical trials, as well as commercial production, regulatory and logistical challenges.</p></sec><sec id="Sec19"><title>Conclusion</title><p id="Par78">This study demonstrated the molecular mimicry between certain parasites and various cancer types, potentially explaining one of the underlying mechanisms of parasites&#x02019; anti-neoplastic activity. Both anti-A<italic>Ts</italic>A and A<italic>Sm</italic>A antibodies revealed cross-reactive antigens with cell extracts from MCF-7 human breast cancer and A549 lung cancer cells at different molecular weights. On the contrary, anti-A<italic>Tg</italic>A antibodies neither reacted with MCF-7 human breast cancer nor A549 lung cancer cell extract.</p><p id="Par79">Results of this study could establish a foundation for subsequent investigation among a broad range of parasites and different types of cancer. Systematic exploration, identification and characterization of parasite/cancer shared antigens could illuminate new pathways for the potential discovery of a novel class of innovative cancer vaccine candidates and therapeutic antibodies of parasitic origin for cancer immunotherapy and targeted therapy.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADCC</term><def><p id="Par2">Antibody-dependent cellular cytotoxicity</p></def></def-item><def-item><term>A<italic>Sm</italic>A</term><def><p id="Par3">Autoclaved <italic>S. mansoni</italic> cercarial antigen</p></def></def-item><def-item><term>A<italic>Tg</italic>A</term><def><p id="Par4">Autoclaved <italic>T. gondii</italic> tachyzoites antigen</p></def></def-item><def-item><term>A<italic>Ts</italic>A</term><def><p id="Par5">Autoclaved <italic>T. spiralis</italic> larval antigen</p></def></def-item><def-item><term><italic>B. jellisoni</italic></term><def><p id="Par6">
<italic>Besnoitia jellisoni</italic>
</p></def></def-item><def-item><term><italic>C. sinensis</italic></term><def><p id="Par7">
<italic>Clonorchis sinensis</italic>
</p></def></def-item><def-item><term><italic>E. granulosus</italic></term><def><p id="Par8">
<italic>Echinococcus granulosus</italic>
</p></def></def-item><def-item><term>FDA</term><def><p id="Par9">Food and drug administration</p></def></def-item><def-item><term>FCA</term><def><p id="Par10">Freund's complete adjuvant</p></def></def-item><def-item><term>HSP</term><def><p id="Par11">Heat shock protein</p></def></def-item><def-item><term>HER-2</term><def><p id="Par12">Human epidermal growth factor receptor-2</p></def></def-item><def-item><term>LL</term><def><p id="Par13">Lewis lung</p></def></def-item><def-item><term><italic>N. caninum</italic></term><def><p id="Par14">
<italic>Neospora caninum</italic>
</p></def></def-item><def-item><term>NF-&#x003ba;B</term><def><p id="Par15">Nuclear factor kappa B</p></def></def-item><def-item><term><italic>O. viverrini</italic></term><def><p id="Par16">
<italic>Opisthorchis viverrini</italic>
</p></def></def-item><def-item><term>PBS</term><def><p id="Par17">Phosphate buffer saline</p></def></def-item><def-item><term>RIPA</term><def><p id="Par18">Radioimmunoprecipitation assay buffer</p></def></def-item><def-item><term><italic>S. equina</italic></term><def><p id="Par19">
<italic>Setaria equina</italic>
</p></def></def-item><def-item><term><italic>S. haematobium</italic></term><def><p id="Par20">
<italic>Schistosoma haematobium</italic>
</p></def></def-item><def-item><term><italic>S. mansoni</italic></term><def><p id="Par21">
<italic>Schistosoma mansoni</italic>
</p></def></def-item><def-item><term>SDS-PAGE</term><def><p id="Par22">Sodium dodecyl polyacrylamide gel electrophoresis</p></def></def-item><def-item><term>STn</term><def><p id="Par23">Sialyl-Tn</p></def></def-item><def-item><term>Spp</term><def><p id="Par24">Species</p></def></def-item><def-item><term>TF</term><def><p id="Par25">Thomsen Friedenreich</p></def></def-item><def-item><term>Tk</term><def><p id="Par26">Thymidine kinase</p></def></def-item><def-item><term>Tn</term><def><p id="Par27">N-acetylgalactosamine O-serine/threonine</p></def></def-item><def-item><term><italic>T. cruzi</italic></term><def><p id="Par28">
<italic>Trypanosoma cruzi</italic>
</p></def></def-item><def-item><term><italic>T. spiralis</italic></term><def><p id="Par29">
<italic>Trichinella spiralis</italic>
</p></def></def-item><def-item><term><italic>T. gondii</italic></term><def><p id="Par30">
<italic>Toxoplasma gondii</italic>
</p></def></def-item><def-item><term>TAAs</term><def><p id="Par31">Tumor-associated antigens</p></def></def-item><def-item><term>TSAs</term><def><p id="Par32">Tumor-specific antigens</p></def></def-item><def-item><term>WHO</term><def><p id="Par33">World Health Organization</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Mrs. Dawlat Ahmed&#x02019;s technical assistant with animal experimentation.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>All authors contributed to the study's conception and design. Material preparation, methodology, validation interpretation of the data, and writing of the original draft were performed by Maha Mohamed Eissa, Sonia Rifaat Ahmed Allam, Cherine Adel Ismail, Rasha Abdelmawla Ghazala, Nahla El Skhawy and Eman Ibrahim El-said Ibrahim. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by The Science, Technology &#x00026; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analyzed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par80">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par81">Experimental animals (mice, rats, and rabbits) were housed in appropriate cages under standard laboratory conditions (27&#x02009;&#x000b1;&#x02009;2&#x000a0;&#x000b0;C; 70&#x02013;80% humidity; 12-h light/dark cycle) with a standard pellet diet and water ad libitum. All experimental animals were handled following the ARRIVE guidelines for animal care and in compliance with the Institutional Animal Care and Use Committee in the Faculty of Medicine, Alexandria University (IACUC; 0201715).</p></notes><notes id="FPar3"><title>Consent to participate</title><p id="Par82">Not applicable.</p></notes><notes id="FPar4"><title>Consent to publish</title><p id="Par83">Not applicable.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">World Health Organization (WHO), Cancer. Fact sheet 2023.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R</given-names></name><name><surname>Bhardwaj</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name></person-group><article-title>Cancer treatment therapies: traditional to modern approaches to combat cancers</article-title><source>Mol Biol Rep</source><year>2023</year><volume>50</volume><issue>11</issue><fpage>9663</fpage><lpage>9676</lpage><pub-id pub-id-type="doi">10.1007/s11033-023-08809-3</pub-id><pub-id pub-id-type="pmid">37828275</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Kaur R, Bhardwaj A, Gupta S (2023) Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep 50(11):9663&#x02013;9676. 10.1007/s11033-023-08809-3<pub-id pub-id-type="pmid">37828275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Rui</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>S</given-names></name></person-group><article-title>Cancer immunotherapies: advances and bottlenecks</article-title><source>Front Immunol</source><year>2023</year><volume>14</volume><fpage>1212476</fpage><lpage>1212493</lpage><pub-id pub-id-type="doi">10.3389/fimmu.2023.1212476</pub-id><pub-id pub-id-type="pmid">37691932</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Rui R, Zhou L, He S (2023) Cancer immunotherapies: advances and bottlenecks. Front Immunol 14:1212476&#x02013;1212493. 10.3389/fimmu.2023.1212476<pub-id pub-id-type="pmid">37691932</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Shuel</surname><given-names>SL</given-names></name></person-group><article-title>Targeted cancer therapies: clinical pearls for primary care</article-title><source>Can Fam Physician</source><year>2022</year><volume>68</volume><issue>7</issue><fpage>515</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.46747/cfp.6807515</pub-id><pub-id pub-id-type="pmid">35831091</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Shuel SL (2022) Targeted cancer therapies: clinical pearls for primary care. Can Fam Physician 68(7):515&#x02013;518. 10.46747/cfp.6807515<pub-id pub-id-type="pmid">35831091</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Feola</surname><given-names>S</given-names></name><name><surname>Chiaro</surname><given-names>J</given-names></name><name><surname>Martins</surname><given-names>B</given-names></name><name><surname>Cerullo</surname><given-names>V</given-names></name></person-group><article-title>Uncovering the tumor antigen landscape: what to know about the discovery process</article-title><source>Cancers</source><year>2020</year><volume>12</volume><issue>6</issue><fpage>1660</fpage><lpage>1688</lpage><pub-id pub-id-type="doi">10.3390/cancers12061660</pub-id><pub-id pub-id-type="pmid">32585818</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Feola S, Chiaro J, Martins B, Cerullo V (2020) Uncovering the tumor antigen landscape: what to know about the discovery process. Cancers 12(6):1660&#x02013;1688. 10.3390/cancers12061660<pub-id pub-id-type="pmid">32585818</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>R</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>FM</given-names></name></person-group><article-title>Antigen discovery for the development of cancer immunotherapy</article-title><source>Semin Immunol</source><year>2023</year><volume>66</volume><fpage>101733</fpage><pub-id pub-id-type="doi">10.1016/j.smim.2023.101733</pub-id><pub-id pub-id-type="pmid">36841147</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Ahn R, Cui Y, White FM (2023) Antigen discovery for the development of cancer immunotherapy. Semin Immunol 66:101733. 10.1016/j.smim.2023.101733<pub-id pub-id-type="pmid">36841147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><article-title>Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: a burdensome journey to promising land</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>153</volume><fpage>113464</fpage><lpage>113475</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.113464</pub-id><pub-id pub-id-type="pmid">36076493</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Yu G, He X, Li X, Wu Y (2022) Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: a burdensome journey to promising land. Biomed Pharmacother 153:113464&#x02013;113475. 10.1016/j.biopha.2022.113464<pub-id pub-id-type="pmid">36076493</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Darani</surname><given-names>HY</given-names></name><name><surname>Yousefi</surname><given-names>M</given-names></name></person-group><article-title>Parasites and cancers: Parasite antigens as possible targets for cancer immunotherapy</article-title><source>Future Oncol</source><year>2012</year><volume>8</volume><issue>12</issue><fpage>1529</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.2217/fon.12.155</pub-id><pub-id pub-id-type="pmid">23231515</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Darani HY, Yousefi M (2012) Parasites and cancers: Parasite antigens as possible targets for cancer immunotherapy. Future Oncol 8(12):1529&#x02013;1535. 10.2217/fon.12.155<pub-id pub-id-type="pmid">23231515</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Callejas</surname><given-names>BE</given-names></name><name><surname>Mart&#x000ed;nez-Saucedo</surname><given-names>D</given-names></name><name><surname>Terrazas</surname><given-names>LI</given-names></name></person-group><article-title>Parasites as negative regulators of cancer</article-title><source>Biosci Rep</source><year>2018</year><volume>38</volume><issue>5</issue><fpage>20180935</fpage><lpage>20180943</lpage><pub-id pub-id-type="doi">10.1042/bsr20180935</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Callejas BE, Mart&#x000ed;nez-Saucedo D, Terrazas LI (2018) Parasites as negative regulators of cancer. Biosci Rep 38(5):20180935&#x02013;20180943. 10.1042/bsr20180935</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefi</surname><given-names>M</given-names></name><name><surname>Akbari</surname><given-names>M</given-names></name><name><surname>Hadipour</surname><given-names>M</given-names></name><name><surname>Dehkordi</surname><given-names>AB</given-names></name><name><surname>Farahbakhsh</surname><given-names>Z</given-names></name><name><surname>Darani</surname><given-names>HY</given-names></name></person-group><article-title>Parasites as potential targets for cancer immunotherapy</article-title><source>J Cancer Res Clin Oncol</source><year>2023</year><volume>149</volume><issue>10</issue><fpage>8027</fpage><lpage>8038</lpage><pub-id pub-id-type="doi">10.1007/s00432-023-04694-2</pub-id><pub-id pub-id-type="pmid">36949175</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Yousefi M, Akbari M, Hadipour M, Dehkordi AB, Farahbakhsh Z, Darani HY (2023) Parasites as potential targets for cancer immunotherapy. J Cancer Res Clin Oncol 149(10):8027&#x02013;8038. 10.1007/s00432-023-04694-2<pub-id pub-id-type="pmid">36949175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Salem</surname><given-names>AE</given-names></name><name><surname>El Skhawy</surname><given-names>N</given-names></name></person-group><article-title>Parasites revive hope for cancer therapy</article-title><source>Eur J Med Res</source><year>2024</year><volume>29</volume><issue>1</issue><fpage>489</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1186/s40001-024-02057-2</pub-id><pub-id pub-id-type="pmid">39367471</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Eissa MM, Salem AE, El Skhawy N (2024) Parasites revive hope for cancer therapy. Eur J Med Res 29(1):489&#x02013;545. 10.1186/s40001-024-02057-2<pub-id pub-id-type="pmid">39367471</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Nyame</surname><given-names>K</given-names></name><name><surname>Cummings</surname><given-names>RD</given-names></name><name><surname>Damian</surname><given-names>RT</given-names></name></person-group><article-title><italic>Schistosoma mansoni</italic> synthesizes glycoproteins containing terminal O-linked N-acetylglucosamine residues</article-title><source>J Biol Chem</source><year>1987</year><volume>262</volume><issue>17</issue><fpage>7990</fpage><lpage>7995</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)47515-1</pub-id><pub-id pub-id-type="pmid">3597358</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Nyame K, Cummings RD, Damian RT (1987) <italic>Schistosoma mansoni</italic> synthesizes glycoproteins containing terminal O-linked N-acetylglucosamine residues. J Biol Chem 262(17):7990&#x02013;7995<pub-id pub-id-type="pmid">3597358</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez Errico</surname><given-names>D</given-names></name><name><surname>Medeiros</surname><given-names>A</given-names></name><name><surname>M&#x000ed;guez</surname><given-names>M</given-names></name><name><surname>Casaravilla</surname><given-names>C</given-names></name><name><surname>Malgor</surname><given-names>R</given-names></name><name><surname>Carmona</surname><given-names>C</given-names></name><etal/></person-group><article-title>O-glycosylation in <italic>Echinococcus granulosus</italic>: Identification and characterization of the carcinoma-associated Tn antigen</article-title><source>Exp Parasitol</source><year>2001</year><volume>98</volume><issue>2</issue><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1006/expr.2001.4620</pub-id><pub-id pub-id-type="pmid">11465993</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Alvarez Errico D, Medeiros A, M&#x000ed;guez M, Casaravilla C, Malgor R, Carmona C et al (2001) O-glycosylation in <italic>Echinococcus granulosus</italic>: Identification and characterization of the carcinoma-associated Tn antigen. Exp Parasitol 98(2):100&#x02013;109. 10.1006/expr.2001.4620<pub-id pub-id-type="pmid">11465993</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Buscaglia</surname><given-names>CA</given-names></name><name><surname>Campo</surname><given-names>VA</given-names></name><name><surname>Frasch</surname><given-names>AC</given-names></name><name><surname>Di Noia</surname><given-names>JM</given-names></name></person-group><article-title><italic>Trypanosoma cruzi</italic> surface mucins: host-dependent coat diversity</article-title><source>Nat Rev Microbiol</source><year>2006</year><volume>4</volume><issue>3</issue><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1351</pub-id><pub-id pub-id-type="pmid">16489349</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Buscaglia CA, Campo VA, Frasch AC, Di Noia JM (2006) <italic>Trypanosoma cruzi</italic> surface mucins: host-dependent coat diversity. Nat Rev Microbiol 4(3):229&#x02013;236. 10.1038/nrmicro1351<pub-id pub-id-type="pmid">16489349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Ubillos</surname><given-names>L</given-names></name><name><surname>Medeiros</surname><given-names>A</given-names></name><name><surname>Cancela</surname><given-names>M</given-names></name><name><surname>Casaravilla</surname><given-names>C</given-names></name><name><surname>Salda&#x000f1;a</surname><given-names>J</given-names></name><name><surname>Dom&#x000ed;nguez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Characterization of the carcinoma-associated Tk antigen in helminth parasites</article-title><source>Exp Parasitol</source><year>2007</year><volume>116</volume><issue>2</issue><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2006.12.009</pub-id><pub-id pub-id-type="pmid">17300782</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ubillos L, Medeiros A, Cancela M, Casaravilla C, Salda&#x000f1;a J, Dom&#x000ed;nguez L et al (2007) Characterization of the carcinoma-associated Tk antigen in helminth parasites. Exp Parasitol 116(2):129&#x02013;136. 10.1016/j.exppara.2006.12.009<pub-id pub-id-type="pmid">17300782</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Casaravilla</surname><given-names>C</given-names></name><name><surname>Malgor</surname><given-names>R</given-names></name><name><surname>Carmona</surname><given-names>C</given-names></name></person-group><article-title>Characterization of carbohydrates of adult <italic>Echinococcus granulosus</italic> by lectin-binding analysis</article-title><source>J Parasitol</source><year>2003</year><volume>89</volume><issue>1</issue><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1645/0022-3395(2003)089[0057:Cocoae]2.0.Co;2</pub-id><pub-id pub-id-type="pmid">12659303</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Casaravilla C, Malgor R, Carmona C (2003) Characterization of carbohydrates of adult <italic>Echinococcus granulosus</italic> by lectin-binding analysis. J Parasitol 89(1):57&#x02013;61. 10.1645/0022-3395(2003)089[0057:Cocoae]2.0.Co;2<pub-id pub-id-type="pmid">12659303</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Thors</surname><given-names>C</given-names></name><name><surname>Jansson</surname><given-names>B</given-names></name><name><surname>Helin</surname><given-names>H</given-names></name><name><surname>Linder</surname><given-names>E</given-names></name></person-group><article-title>Thomsen-Friedenreich oncofetal antigen in <italic>Schistosoma mansoni</italic> : localization and immunogenicity in experimental mouse infection</article-title><source>Parasitology</source><year>2006</year><volume>132</volume><issue>Pt 1</issue><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1017/s003118200500867x</pub-id><pub-id pub-id-type="pmid">16393356</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Thors C, Jansson B, Helin H, Linder E (2006) Thomsen-Friedenreich oncofetal antigen in <italic>Schistosoma mansoni</italic>&#x0202f;: localization and immunogenicity in experimental mouse infection. Parasitology 132(Pt 1):73&#x02013;81. 10.1017/s003118200500867x<pub-id pub-id-type="pmid">16393356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>T</given-names></name><name><surname>Casaravilla</surname><given-names>C</given-names></name><name><surname>Carmona</surname><given-names>C</given-names></name><name><surname>Osinaga</surname><given-names>E</given-names></name></person-group><article-title>Mucin-type O-glycosylation in <italic>Fasciola hepatica</italic>: Characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity</article-title><source>Int J Parasitol</source><year>2003</year><volume>33</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/s0020-7519(02)00231-x</pub-id><pub-id pub-id-type="pmid">12547345</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Freire T, Casaravilla C, Carmona C, Osinaga E (2003) Mucin-type O-glycosylation in <italic>Fasciola hepatica</italic>: Characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity. Int J Parasitol 33(1):47&#x02013;56. 10.1016/s0020-7519(02)00231-x<pub-id pub-id-type="pmid">12547345</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Pollevick</surname><given-names>GD</given-names></name><name><surname>Di Noia</surname><given-names>JM</given-names></name><name><surname>Salto</surname><given-names>ML</given-names></name><name><surname>Lima</surname><given-names>C</given-names></name><name><surname>Leguizam&#x000f3;n</surname><given-names>MS</given-names></name><name><surname>de Lederkremer</surname><given-names>RM</given-names></name><etal/></person-group><article-title><italic>Trypanosoma cruzi</italic> surface mucins with exposed variant epitopes</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><issue>36</issue><fpage>27671</fpage><lpage>27680</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000253200</pub-id><pub-id pub-id-type="pmid">10843987</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Pollevick GD, Di Noia JM, Salto ML, Lima C, Leguizam&#x000f3;n MS, de Lederkremer RM et al (2000) <italic>Trypanosoma cruzi</italic> surface mucins with exposed variant epitopes. J Biol Chem 275(36):27671&#x02013;27680. 10.1074/jbc.M000253200<pub-id pub-id-type="pmid">10843987</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Tomavo</surname><given-names>S</given-names></name></person-group><article-title>The major surface proteins of <italic>Toxoplasma gondii</italic>: Structures and functions</article-title><source>Curr Top Microbiol Immunol</source><year>1996</year><volume>219</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-51014-4_4</pub-id><pub-id pub-id-type="pmid">8791687</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Tomavo S (1996) The major surface proteins of <italic>Toxoplasma gondii</italic>: Structures and functions. Curr Top Microbiol Immunol 219:45&#x02013;54. 10.1007/978-3-642-51014-4_4<pub-id pub-id-type="pmid">8791687</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Wojczyk</surname><given-names>BS</given-names></name><name><surname>Stwora-Wojczyk</surname><given-names>MM</given-names></name><name><surname>Hagen</surname><given-names>FK</given-names></name><name><surname>Striepen</surname><given-names>B</given-names></name><name><surname>Hang</surname><given-names>HC</given-names></name><name><surname>Bertozzi</surname><given-names>CR</given-names></name><etal/></person-group><article-title>cDNA cloning and expression of UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase T1 from <italic>Toxoplasma gondii</italic></article-title><source>Mol Biochem Parasitol</source><year>2003</year><volume>131</volume><issue>2</issue><fpage>93</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/s0166-6851(03)00196-8</pub-id><pub-id pub-id-type="pmid">14511808</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Wojczyk BS, Stwora-Wojczyk MM, Hagen FK, Striepen B, Hang HC, Bertozzi CR et al (2003) cDNA cloning and expression of UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase T1 from <italic>Toxoplasma gondii</italic>. Mol Biochem Parasitol 131(2):93&#x02013;107. 10.1016/s0166-6851(03)00196-8<pub-id pub-id-type="pmid">14511808</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><issue>9</issue><fpage>24407</fpage><lpage>24417</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0024407</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chen L, He Z, Qin L, Li Q, Shi X, Zhao S et al (2011) Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS ONE 6(9):24407&#x02013;24417. 10.1371/journal.pone.0024407</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Adah</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Gadidasu</surname><given-names>K</given-names></name><name><surname>Tao</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><etal/></person-group><article-title><italic>Plasmodium</italic> infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model</article-title><source>Cell Commun Signal</source><year>2019</year><volume>17</volume><issue>1</issue><fpage>32</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1186/s12964-019-0342-6</pub-id><pub-id pub-id-type="pmid">30979375</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Adah D, Yang Y, Liu Q, Gadidasu K, Tao Z, Yu S et al (2019) <italic>Plasmodium</italic> infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model. Cell Commun Signal 17(1):32&#x02013;44. 10.1186/s12964-019-0342-6<pub-id pub-id-type="pmid">30979375</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Attenuated <italic>Plasmodium</italic> sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice</article-title><source>Cancer Biol Med</source><year>2019</year><volume>16</volume><issue>2</issue><fpage>288</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.20892/j.issn.2095-3941.2018.0309</pub-id><pub-id pub-id-type="pmid">31516749</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Zhou D, Zheng H, Liu Q, Lu X, Deng X, Jiang L et al (2019) Attenuated <italic>Plasmodium</italic> sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice. Cancer Biol Med 16(2):288&#x02013;298. 10.20892/j.issn.2095-3941.2018.0309<pub-id pub-id-type="pmid">31516749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JO</given-names></name><name><surname>Jung</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Shin</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Inhibition of Lewis lung carcinoma growth by <italic>Toxoplasma gondii</italic> through induction of Th1 immune responses and inhibition of angiogenesis</article-title><source>J Korean Med Sci</source><year>2007</year><volume>22</volume><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.3346/jkms.2007.22.S.S38</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Kim JO, Jung SS, Kim SY, Kim TY, Shin DW, Lee JH et al (2007) Inhibition of Lewis lung carcinoma growth by <italic>Toxoplasma gondii</italic> through induction of Th1 immune responses and inhibition of angiogenesis. J Korean Med Sci 22:38&#x02013;46. 10.3346/jkms.2007.22.S.S38</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>SG</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Ham</surname><given-names>DW</given-names></name><name><surname>Shin</surname><given-names>EH</given-names></name></person-group><article-title><italic>Toxoplasma</italic> GRA16 inhibits nf-&#x003ba;b activation through PP2a-b55 upregulation in non-small-cell lung carcinoma cells</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>18</issue><fpage>6642</fpage><lpage>6658</lpage><pub-id pub-id-type="doi">10.3390/ijms21186642</pub-id><pub-id pub-id-type="pmid">32927892</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Seo SH, Kim SG, Shin JH, Ham DW, Shin EH (2020) <italic>Toxoplasma</italic> GRA16 inhibits nf-&#x003ba;b activation through PP2a-b55 upregulation in non-small-cell lung carcinoma cells. Int J Mol Sci 21(18):6642&#x02013;6658. 10.3390/ijms21186642<pub-id pub-id-type="pmid">32927892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Trudeau</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Galipeau</surname><given-names>J</given-names></name><name><surname>Benlimame</surname><given-names>N</given-names></name><name><surname>Alaoui-Jamali</surname><given-names>MA</given-names></name><name><surname>Batist</surname><given-names>G</given-names></name></person-group><article-title>A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells</article-title><source>Hum Gene Ther</source><year>2001</year><volume>12</volume><issue>13</issue><fpage>1673</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1089/10430340152528165</pub-id><pub-id pub-id-type="pmid">11535170</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Trudeau C, Yuan S, Galipeau J, Benlimame N, Alaoui-Jamali MA, Batist G (2001) A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells. Hum Gene Ther 12(13):1673&#x02013;1680. 10.1089/10430340152528165<pub-id pub-id-type="pmid">11535170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>T</given-names></name><name><surname>Landeira</surname><given-names>M</given-names></name><name><surname>Giacomini</surname><given-names>C</given-names></name><name><surname>Festari</surname><given-names>MF</given-names></name><name><surname>Pittini</surname><given-names>&#x000c1;</given-names></name><name><surname>Cardozo</surname><given-names>V</given-names></name><etal/></person-group><article-title><italic>Trypanosoma cruzi</italic>-derived molecules induce anti-tumour protection by favouring both innate and adaptive immune responses</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>23</issue><fpage>15032</fpage><lpage>15050</lpage><pub-id pub-id-type="doi">10.3390/ijms232315032</pub-id><pub-id pub-id-type="pmid">36499361</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Freire T, Landeira M, Giacomini C, Festari MF, Pittini &#x000c1;, Cardozo V et al (2022) <italic>Trypanosoma cruzi</italic>-derived molecules induce anti-tumour protection by favouring both innate and adaptive immune responses. Int J Mol Sci 23(23):15032&#x02013;15050. 10.3390/ijms232315032<pub-id pub-id-type="pmid">36499361</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Salvador-Membreve</surname><given-names>DM</given-names></name><name><surname>Jacinto</surname><given-names>SD</given-names></name><name><surname>Rivera</surname><given-names>WL</given-names></name></person-group><article-title><italic>Trichomonas vaginali</italic>s induces cytopathic effect on human lung alveolar basal carcinoma epithelial cell line A549</article-title><source>Exp Parasitol</source><year>2014</year><volume>147</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2014.10.003</pub-id><pub-id pub-id-type="pmid">25307688</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Salvador-Membreve DM, Jacinto SD, Rivera WL (2014) <italic>Trichomonas vaginali</italic>s induces cytopathic effect on human lung alveolar basal carcinoma epithelial cell line A549. Exp Parasitol 147:33&#x02013;40. 10.1016/j.exppara.2014.10.003<pub-id pub-id-type="pmid">25307688</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Karadayi</surname><given-names>S</given-names></name><name><surname>Arslan</surname><given-names>S</given-names></name><name><surname>Sumer</surname><given-names>Z</given-names></name><name><surname>Turan</surname><given-names>M</given-names></name><name><surname>Sumer</surname><given-names>H</given-names></name><name><surname>Karadayi</surname><given-names>K</given-names></name></person-group><article-title>Does hydatid disease have protective effects against lung cancer?</article-title><source>Mol Biol Rep</source><year>2013</year><volume>40</volume><issue>8</issue><fpage>4701</fpage><lpage>4704</lpage><pub-id pub-id-type="doi">10.1007/s11033-013-2565-8</pub-id><pub-id pub-id-type="pmid">23645038</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Karadayi S, Arslan S, Sumer Z, Turan M, Sumer H, Karadayi K (2013) Does hydatid disease have protective effects against lung cancer? Mol Biol Rep 40(8):4701&#x02013;4704. 10.1007/s11033-013-2565-8<pub-id pub-id-type="pmid">23645038</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Berriel</surname><given-names>E</given-names></name><name><surname>Freire</surname><given-names>T</given-names></name><name><surname>Chiale</surname><given-names>C</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>E</given-names></name><name><surname>Mor&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Fern&#x000e1;ndez-Gra&#x000f1;a</surname><given-names>G</given-names></name><etal/></person-group><article-title>Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1.1(+) cell activation in mice</article-title><source>Cancer Immunol Immunother</source><year>2021</year><volume>70</volume><issue>12</issue><fpage>3617</fpage><lpage>3627</lpage><pub-id pub-id-type="doi">10.1007/s00262-021-02948-x</pub-id><pub-id pub-id-type="pmid">33944981</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Berriel E, Freire T, Chiale C, Rodr&#x000ed;guez E, Mor&#x000f3;n G, Fern&#x000e1;ndez-Gra&#x000f1;a G et al (2021) Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1.1(+) cell activation in mice. Cancer Immunol Immunother 70(12):3617&#x02013;3627. 10.1007/s00262-021-02948-x<pub-id pub-id-type="pmid">33944981</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>WP</given-names></name><etal/></person-group><article-title>Transcriptome profiling of A549 non-small cell lung cancer cells in response to <italic>Trichinella spiralis</italic> muscle larvae excretory/secretory products</article-title><source>Front Vet Sci</source><year>2023</year><volume>10</volume><fpage>1208538</fpage><lpage>1208549</lpage><pub-id pub-id-type="doi">10.3389/fvets.2023.1208538</pub-id><pub-id pub-id-type="pmid">37601754</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wang H, Zhu Y, Li M, Pan J, Li D, Guo WP et al (2023) Transcriptome profiling of A549 non-small cell lung cancer cells in response to <italic>Trichinella spiralis</italic> muscle larvae excretory/secretory products. Front Vet Sci 10:1208538&#x02013;1208549. 10.3389/fvets.2023.1208538<pub-id pub-id-type="pmid">37601754</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and <italic>Trichinella spiralis</italic></article-title><source>Artif Cells Nanomed Biotechnol</source><year>2024</year><volume>52</volume><issue>1</issue><fpage>300</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1080/21691401.2024.2347377</pub-id><pub-id pub-id-type="pmid">38753524</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Yue T, Wang J, Liu F, Gong P, Li J, Zhang X et al (2024) The effects of anti-lung cancer in nude mice by a fully human single-chain antibody against associated antigen Ts7TMR between A549 cells and <italic>Trichinella spiralis</italic>. Artif Cells Nanomed Biotechnol 52(1):300&#x02013;308. 10.1080/21691401.2024.2347377<pub-id pub-id-type="pmid">38753524</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Kang</surname><given-names>Z</given-names></name><name><surname>Adah</surname><given-names>D</given-names></name><name><surname>Tao</surname><given-names>Z</given-names></name><etal/></person-group><article-title><italic>Plasmodium</italic> infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8<sup>(+)</sup> T cell-mediated antitumor responses in mice</article-title><source>Biomed Pharmacother</source><year>2021</year><volume>138</volume><fpage>111406</fpage><lpage>111415</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2021.111406</pub-id><pub-id pub-id-type="pmid">33676307</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Pan J, Ma M, Qin L, Kang Z, Adah D, Tao Z et al (2021) <italic>Plasmodium</italic> infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8<sup>(+)</sup> T cell-mediated antitumor responses in mice. Biomed Pharmacother 138:111406&#x02013;111415. 10.1016/j.biopha.2021.111406<pub-id pub-id-type="pmid">33676307</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>LQ</given-names></name><name><surname>Yao</surname><given-names>LJ</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>LJ</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>WZ</given-names></name><etal/></person-group><article-title>A uracil auxotroph <italic>Toxoplasma gondii</italic> exerting immunomodulation to inhibit breast cancer growth and metastasis</article-title><source>Parasit Vect</source><year>2021</year><volume>14</volume><issue>1</issue><fpage>601</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1186/s13071-021-05032-6</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Xu LQ, Yao LJ, Jiang D, Zhou LJ, Chen M, Liao WZ et al (2021) A uracil auxotroph <italic>Toxoplasma gondii</italic> exerting immunomodulation to inhibit breast cancer growth and metastasis. Parasit Vect 14(1):601&#x02013;614. 10.1186/s13071-021-05032-6</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>CA</given-names></name><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Gaafar</surname><given-names>MR</given-names></name><name><surname>Younis</surname><given-names>LK</given-names></name><name><surname>El Skhawy</surname><given-names>N</given-names></name></person-group><article-title><italic>Toxoplasma gondii</italic>-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide</article-title><source>Med Oncol</source><year>2023</year><volume>40</volume><issue>5</issue><fpage>136</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1007/s12032-023-01994-y</pub-id><pub-id pub-id-type="pmid">37014499</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Ismail CA, Eissa MM, Gaafar MR, Younis LK, El Skhawy N (2023) <italic>Toxoplasma gondii</italic>-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide. Med Oncol 40(5):136&#x02013;149. 10.1007/s12032-023-01994-y<pub-id pub-id-type="pmid">37014499</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Gaafar</surname><given-names>MR</given-names></name><name><surname>Younis</surname><given-names>LK</given-names></name><name><surname>Ismail</surname><given-names>CA</given-names></name><name><surname>El Skhawy</surname><given-names>N</given-names></name></person-group><article-title>Prophylactic antineoplastic activity of <italic>Toxoplasma gondii</italic> RH derived antigen against Ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting</article-title><source>Infect Agent Cancer</source><year>2023</year><volume>18</volume><issue>1</issue><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1186/s13027-023-00500-3</pub-id><pub-id pub-id-type="pmid">37029378</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Eissa MM, Gaafar MR, Younis LK, Ismail CA, El Skhawy N (2023) Prophylactic antineoplastic activity of <italic>Toxoplasma gondii</italic> RH derived antigen against Ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting. Infect Agent Cancer 18(1):21&#x02013;34. 10.1186/s13027-023-00500-3<pub-id pub-id-type="pmid">37029378</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title><italic>Neospora caninum</italic>: In vitro culture of tachyzoites in MCF-7 human breast carcinoma cells</article-title><source>Exp Parasitol</source><year>2010</year><volume>126</volume><issue>4</issue><fpage>536</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2010.06.006</pub-id><pub-id pub-id-type="pmid">20566363</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lv Q, Li J, Gong P, Xing S, Zhang X (2010) <italic>Neospora caninum</italic>: In vitro culture of tachyzoites in MCF-7 human breast carcinoma cells. Exp Parasitol 126(4):536&#x02013;539. 10.1016/j.exppara.2010.06.006<pub-id pub-id-type="pmid">20566363</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Hibbs</surname><given-names>JB</given-names><suffix>Jr</suffix></name><name><surname>Lambert</surname><given-names>LH</given-names><suffix>Jr</suffix></name><name><surname>Remington</surname><given-names>JS</given-names></name></person-group><article-title>Resistance to murine tumors conferred by chronic infection with intracellular protozoa, <italic>Toxoplasma gondii</italic> and <italic>Besnoitia jellisoni</italic></article-title><source>J Infect Dis</source><year>1971</year><volume>124</volume><issue>6</issue><fpage>587</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1093/infdis/124.6.587</pub-id><pub-id pub-id-type="pmid">5127071</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Hibbs JB Jr, Lambert LH Jr, Remington JS (1971) Resistance to murine tumors conferred by chronic infection with intracellular protozoa, <italic>Toxoplasma gondii</italic> and <italic>Besnoitia jellisoni</italic>. J Infect Dis 124(6):587&#x02013;592. 10.1093/infdis/124.6.587<pub-id pub-id-type="pmid">5127071</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Ubillos</surname><given-names>L</given-names></name><name><surname>Freire</surname><given-names>T</given-names></name><name><surname>Berriel</surname><given-names>E</given-names></name><name><surname>Chiribao</surname><given-names>ML</given-names></name><name><surname>Chiale</surname><given-names>C</given-names></name><name><surname>Festari</surname><given-names>MF</given-names></name><etal/></person-group><article-title><italic>Trypanosoma cruzi</italic> extracts elicit protective immune response against chemically induced colon and mammary cancers</article-title><source>Int J Cancer</source><year>2016</year><volume>138</volume><issue>7</issue><fpage>1719</fpage><lpage>1731</lpage><pub-id pub-id-type="doi">10.1002/ijc.29910</pub-id><pub-id pub-id-type="pmid">26519949</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ubillos L, Freire T, Berriel E, Chiribao ML, Chiale C, Festari MF et al (2016) <italic>Trypanosoma cruzi</italic> extracts elicit protective immune response against chemically induced colon and mammary cancers. Int J Cancer 138(7):1719&#x02013;1731. 10.1002/ijc.29910<pub-id pub-id-type="pmid">26519949</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Zenina</surname><given-names>AV</given-names></name><name><surname>Kravtsov</surname><given-names>EG</given-names></name><name><surname>Tsetsegsaikhan</surname><given-names>B</given-names></name><name><surname>Yashina</surname><given-names>NV</given-names></name><name><surname>Dalin</surname><given-names>MV</given-names></name><name><surname>Karpenko</surname><given-names>LP</given-names></name><etal/></person-group><article-title>The study of immunological component in antitumor effect of <italic>Trypanosoma cruzi</italic></article-title><source>Bull Exp Biol Med</source><year>2008</year><volume>145</volume><issue>3</issue><fpage>352</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1007/s10517-008-0089-3</pub-id><pub-id pub-id-type="pmid">19039942</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Zenina AV, Kravtsov EG, Tsetsegsaikhan B, Yashina NV, Dalin MV, Karpenko LP et al (2008) The study of immunological component in antitumor effect of <italic>Trypanosoma cruzi</italic>. Bull Exp Biol Med 145(3):352&#x02013;354. 10.1007/s10517-008-0089-3<pub-id pub-id-type="pmid">19039942</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Caner</surname><given-names>A</given-names></name><name><surname>Sad&#x00131;qova</surname><given-names>A</given-names></name><name><surname>Erdo&#x0011f;an</surname><given-names>A</given-names></name><name><surname>Naml&#x00131;ses</surname><given-names>D</given-names></name><name><surname>Nalbantsoy</surname><given-names>A</given-names></name><name><surname>Oltulu</surname><given-names>F</given-names></name><etal/></person-group><article-title>Targeting of antitumor &#x00131;mmune responses with live-attenuated <italic>Leishmania</italic> strains in breast cancer model</article-title><source>Breast Cancer</source><year>2020</year><volume>27</volume><issue>6</issue><fpage>1082</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1007/s12282-020-01112-0</pub-id><pub-id pub-id-type="pmid">32472473</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Caner A, Sad&#x00131;qova A, Erdo&#x0011f;an A, Naml&#x00131;ses D, Nalbantsoy A, Oltulu F et al (2020) Targeting of antitumor &#x00131;mmune responses with live-attenuated <italic>Leishmania</italic> strains in breast cancer model. Breast Cancer 27(6):1082&#x02013;1095. 10.1007/s12282-020-01112-0<pub-id pub-id-type="pmid">32472473</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Ranasinghe</surname><given-names>SL</given-names></name><name><surname>Boyle</surname><given-names>GM</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Potriquet</surname><given-names>J</given-names></name><name><surname>Mulvenna</surname><given-names>JP</given-names></name><name><surname>McManus</surname><given-names>DP</given-names></name></person-group><article-title>Kunitz type protease inhibitor EgKI-1 from the canine tapeworm <italic>Echinococcus granulosus</italic> as a promising therapeutic against breast cancer</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><issue>8</issue><fpage>200433</fpage><lpage>200449</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0200433</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ranasinghe SL, Boyle GM, Fischer K, Potriquet J, Mulvenna JP, McManus DP (2018) Kunitz type protease inhibitor EgKI-1 from the canine tapeworm <italic>Echinococcus granulosus</italic> as a promising therapeutic against breast cancer. PLoS ONE 13(8):200433&#x02013;200449. 10.1371/journal.pone.0200433</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Daneshpour</surname><given-names>S</given-names></name><name><surname>Kefayat</surname><given-names>AH</given-names></name><name><surname>Mofid</surname><given-names>MR</given-names></name><name><surname>Rostami Rad</surname><given-names>S</given-names></name><name><surname>Yousofi</surname><given-names>DH</given-names></name></person-group><article-title>Effect of hydatid cyst fluid antigens on induction of apoptosis on breast cancer cells</article-title><source>Adv Biomed Res</source><year>2019</year><volume>8</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.4103/abr.abr_220_18</pub-id><pub-id pub-id-type="pmid">31123670</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Daneshpour S, Kefayat AH, Mofid MR, Rostami Rad S, Yousofi DH (2019) Effect of hydatid cyst fluid antigens on induction of apoptosis on breast cancer cells. Adv Biomed Res 8:27&#x02013;35. 10.4103/abr.abr_220_18<pub-id pub-id-type="pmid">31123670</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Jafari</surname><given-names>H</given-names></name><name><surname>Mahami-Oskouei</surname><given-names>M</given-names></name><name><surname>Spotin</surname><given-names>A</given-names></name><name><surname>Baradaran</surname><given-names>B</given-names></name><name><surname>Shanehbandi</surname><given-names>D</given-names></name><name><surname>Baghbanzadeh</surname><given-names>A</given-names></name><etal/></person-group><article-title>MicroRNA-1 inhibits the growth of breast cancer cells MBA-MB-231 and MCF-7 treated with hydatid cyst fluid</article-title><source>J Trop Med</source><year>2024</year><volume>2024</volume><fpage>7474039</fpage><pub-id pub-id-type="doi">10.1155/2024/7474039</pub-id><pub-id pub-id-type="pmid">38504949</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Jafari H, Mahami-Oskouei M, Spotin A, Baradaran B, Shanehbandi D, Baghbanzadeh A et al (2024) MicroRNA-1 inhibits the growth of breast cancer cells MBA-MB-231 and MCF-7 treated with hydatid cyst fluid. J Trop Med 2024:7474039. 10.1155/2024/7474039<pub-id pub-id-type="pmid">38504949</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Schcolnik-Cabrera</surname><given-names>A</given-names></name><name><surname>Ju&#x000e1;rez</surname><given-names>M</given-names></name><name><surname>Oldak</surname><given-names>B</given-names></name><name><surname>Cruz-Rivera</surname><given-names>M</given-names></name><name><surname>Flisser</surname><given-names>A</given-names></name><name><surname>Due&#x000f1;as-Gonz&#x000e1;lez</surname><given-names>A</given-names></name><etal/></person-group><article-title>In vitro employment of recombinant <italic>Taenia solium</italic> calreticulin as a novel strategy against breast and ovarian cancer stem-like cells</article-title><source>Arch Med Res</source><year>2020</year><volume>51</volume><issue>1</issue><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2019.12.003</pub-id><pub-id pub-id-type="pmid">32097797</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Schcolnik-Cabrera A, Ju&#x000e1;rez M, Oldak B, Cruz-Rivera M, Flisser A, Due&#x000f1;as-Gonz&#x000e1;lez A et al (2020) In vitro employment of recombinant <italic>Taenia solium</italic> calreticulin as a novel strategy against breast and ovarian cancer stem-like cells. Arch Med Res 51(1):65&#x02013;75. 10.1016/j.arcmed.2019.12.003<pub-id pub-id-type="pmid">32097797</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name></person-group><article-title>Analysis of genes differentially expressed by MCF-7 cells challenged with <italic>Trichinella spiralis</italic> larval antigen</article-title><source>Zhongguo bing yuan sheng wu xue za zhi</source><year>2019</year><volume>14</volume><issue>7</issue><fpage>750</fpage><lpage>754</lpage></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Wang X, Huang X, Li H, Yang S, Wang G, Yuan H (2019) Analysis of genes differentially expressed by MCF-7 cells challenged with <italic>Trichinella spiralis</italic> larval antigen. Zhongguo bing yuan sheng wu xue za zhi 14(7):750&#x02013;754</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Eissa MM, Allam SR, A. IC, Ghazala R A, El Skhawy N, Zaki II et al. (2025) Unveiling the anti-neoplastic potential of <italic>Schistosoma mansoni</italic>-derived antigen against breast cancer: A pre-clinical study Under Publication.</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Homan</surname><given-names>WL</given-names></name><name><surname>Derksen</surname><given-names>AC</given-names></name><name><surname>van Knapen</surname><given-names>F</given-names></name></person-group><article-title>Identification of diagnostic antigens from <italic>Trichinella spiralis</italic></article-title><source>Parasitol Res</source><year>1992</year><volume>78</volume><issue>2</issue><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1007/bf00931651</pub-id><pub-id pub-id-type="pmid">1557322</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Homan WL, Derksen AC, van Knapen F (1992) Identification of diagnostic antigens from <italic>Trichinella spiralis</italic>. Parasitol Res 78(2):112&#x02013;119. 10.1007/bf00931651<pub-id pub-id-type="pmid">1557322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Mostafa</surname><given-names>DK</given-names></name><name><surname>Ghazy</surname><given-names>AA</given-names></name><name><surname>El Azzouni</surname><given-names>MZ</given-names></name><name><surname>Boulos</surname><given-names>LM</given-names></name><name><surname>Younis</surname><given-names>LK</given-names></name></person-group><article-title>Anti-arthritic activity of <italic>Schistosoma mansoni</italic> and <italic>Trichinella spiralis</italic> derived-antigens in adjuvant arthritis in rats: role of FOXP3<sup>+</sup> Treg Cells</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>11</issue><fpage>165916</fpage><lpage>165936</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0165916</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Eissa MM, Mostafa DK, Ghazy AA, El Azzouni MZ, Boulos LM, Younis LK (2016) Anti-arthritic activity of <italic>Schistosoma mansoni</italic> and <italic>Trichinella spiralis</italic> derived-antigens in adjuvant arthritis in rats: role of FOXP3<sup>+</sup> Treg Cells. PLoS ONE 11(11):165916&#x02013;165936. 10.1371/journal.pone.0165916</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>N</given-names></name></person-group><article-title>Experimental chemotherapy of Schistosomiasis mansoni</article-title><source>Adv Parasitol</source><year>1968</year><volume>6</volume><fpage>233</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/s0065-308x(08)60475-3</pub-id><pub-id pub-id-type="pmid">4978052</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Pellegrino J, Katz N (1968) Experimental chemotherapy of Schistosomiasis mansoni. Adv Parasitol 6:233&#x02013;290. 10.1016/s0065-308x(08)60475-3<pub-id pub-id-type="pmid">4978052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Ismail</surname><given-names>CA</given-names></name><name><surname>El-Azzouni</surname><given-names>MZ</given-names></name><name><surname>Ghazy</surname><given-names>AA</given-names></name><name><surname>Hadi</surname><given-names>MA</given-names></name></person-group><article-title>Immuno-therapeutic potential of <italic>Schistosoma mansoni</italic> and <italic>Trichinella spiralis</italic> antigens in a murine model of colon cancer</article-title><source>Invest New Drugs</source><year>2019</year><volume>37</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s10637-018-0609-6</pub-id><pub-id pub-id-type="pmid">29808307</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Eissa MM, Ismail CA, El-Azzouni MZ, Ghazy AA, Hadi MA (2019) Immuno-therapeutic potential of <italic>Schistosoma mansoni</italic> and <italic>Trichinella spiralis</italic> antigens in a murine model of colon cancer. Invest New Drugs 37(1):47&#x02013;56. 10.1007/s10637-018-0609-6<pub-id pub-id-type="pmid">29808307</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>DJ</given-names></name><name><surname>Hutchison</surname><given-names>WM</given-names></name></person-group><article-title>Comparison of the development of avirulent and virulent strains of <italic>Toxoplasma gondii</italic> in the peritoneal exudate of mice</article-title><source>Ann Trop Med Parasitol</source><year>1981</year><volume>75</volume><issue>5</issue><fpage>539</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1080/00034983.1981.11687478</pub-id><pub-id pub-id-type="pmid">7316579</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Ferguson DJ, Hutchison WM (1981) Comparison of the development of avirulent and virulent strains of <italic>Toxoplasma gondii</italic> in the peritoneal exudate of mice. Ann Trop Med Parasitol 75(5):539&#x02013;546. 10.1080/00034983.1981.11687478<pub-id pub-id-type="pmid">7316579</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Zumaquero-R&#x000ed;os</surname><given-names>JL</given-names></name><name><surname>Garc&#x000ed;a-Juarez</surname><given-names>J</given-names></name><name><surname>de la Rosa-Arana</surname><given-names>JL</given-names></name><name><surname>Marcet</surname><given-names>R</given-names></name><name><surname>Sarracent-P&#x000e9;rez</surname><given-names>J</given-names></name></person-group><article-title><italic>Trichinella spiralis</italic>: monoclonal antibody against the muscular larvae for the detection of circulating and fecal antigens in experimentally infected rats</article-title><source>Exp Parasitol</source><year>2012</year><volume>132</volume><issue>4</issue><fpage>444</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2012.09.016</pub-id><pub-id pub-id-type="pmid">23026455</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Zumaquero-R&#x000ed;os JL, Garc&#x000ed;a-Juarez J, de la Rosa-Arana JL, Marcet R, Sarracent-P&#x000e9;rez J (2012) <italic>Trichinella spiralis</italic>: monoclonal antibody against the muscular larvae for the detection of circulating and fecal antigens in experimentally infected rats. Exp Parasitol 132(4):444&#x02013;449. 10.1016/j.exppara.2012.09.016<pub-id pub-id-type="pmid">23026455</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Doenhoff</surname><given-names>MJ</given-names></name><name><surname>El-Faham</surname><given-names>M</given-names></name><name><surname>Liddell</surname><given-names>S</given-names></name><name><surname>Fuller</surname><given-names>HR</given-names></name><name><surname>Stanley</surname><given-names>RG</given-names></name><name><surname>Schramm</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cross-reactivity between <italic>Schistosoma mansoni</italic> antigens and the latex allergen hev b 7: putative implication of cross-reactive carbohydrate determinants (CCDS)</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><issue>7</issue><fpage>159542</fpage><lpage>159564</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0159542</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Doenhoff MJ, El-Faham M, Liddell S, Fuller HR, Stanley RG, Schramm G et al (2016) Cross-reactivity between <italic>Schistosoma mansoni</italic> antigens and the latex allergen hev b 7: putative implication of cross-reactive carbohydrate determinants (CCDS). PLoS ONE 11(7):159542&#x02013;159564. 10.1371/journal.pone.0159542</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Doenhoff</surname><given-names>MJ</given-names></name><name><surname>Modha</surname><given-names>J</given-names></name><name><surname>Curtis</surname><given-names>RH</given-names></name><name><surname>Adeoye</surname><given-names>GO</given-names></name></person-group><article-title>Immunological identification of <italic>Schistosoma mansoni</italic> peptidases</article-title><source>Mol Biochem Parasitol</source><year>1988</year><volume>31</volume><issue>3</issue><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/0166-6851(88)90153-3</pub-id><pub-id pub-id-type="pmid">3221910</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Doenhoff MJ, Modha J, Curtis RH, Adeoye GO (1988) Immunological identification of <italic>Schistosoma mansoni</italic> peptidases. Mol Biochem Parasitol 31(3):233&#x02013;240. 10.1016/0166-6851(88)90153-3<pub-id pub-id-type="pmid">3221910</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Verma J, Saxena S, Babu SG. (2012) ELISA-based identification and detection of microbes. In: Analyzing microbes: manual of molecular biology Techniques: Springer. pp 169&#x02013;86.</mixed-citation></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamadi</surname><given-names>F</given-names></name><name><surname>Shakibapour</surname><given-names>M</given-names></name><name><surname>Sharafi</surname><given-names>SM</given-names></name><name><surname>Reza</surname><given-names>AA</given-names></name><name><surname>Tolouei</surname><given-names>S</given-names></name><name><surname>Darani</surname><given-names>HY</given-names></name></person-group><article-title>Anti-<italic>Toxoplasma gondii</italic> antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes</article-title><source>Biomed Rep</source><year>2019</year><volume>10</volume><issue>3</issue><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.3892/br.2019.1186</pub-id><pub-id pub-id-type="pmid">30906547</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Mohamadi F, Shakibapour M, Sharafi SM, Reza AA, Tolouei S, Darani HY (2019) Anti-<italic>Toxoplasma gondii</italic> antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes. Biomed Rep 10(3):183&#x02013;188. 10.3892/br.2019.1186<pub-id pub-id-type="pmid">30906547</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Litovchick</surname><given-names>L</given-names></name></person-group><article-title>Preparing whole-cell lysates for immunoblotting</article-title><source>Cold Spring Harb Protoc</source><year>2018</year><volume>2018</volume><issue>7</issue><fpage>984</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot098400</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Litovchick L (2018) Preparing whole-cell lysates for immunoblotting. Cold Spring Harb Protoc 2018(7):984&#x02013;999</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Kal&#x00131;n</surname><given-names>&#x0015e;N</given-names></name><name><surname>Altay</surname><given-names>A</given-names></name><name><surname>Budak</surname><given-names>H</given-names></name></person-group><article-title>Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach</article-title><source>J Appl Toxicol</source><year>2023</year><volume>43</volume><issue>8</issue><fpage>1148</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1002/jat.4451</pub-id><pub-id pub-id-type="pmid">36807289</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Kal&#x00131;n &#x0015e;N, Altay A, Budak H (2023) Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach. J Appl Toxicol 43(8):1148&#x02013;1158. 10.1002/jat.4451<pub-id pub-id-type="pmid">36807289</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Garfin</surname><given-names>DE</given-names></name></person-group><article-title>One-dimensional gel electrophoresis</article-title><source>Methods Enzymol</source><year>2009</year><volume>463</volume><fpage>497</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/s0076-6879(09)63029-9</pub-id><pub-id pub-id-type="pmid">19892189</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Garfin DE (2009) One-dimensional gel electrophoresis. Methods Enzymol 463:497&#x02013;513. 10.1016/s0076-6879(09)63029-9<pub-id pub-id-type="pmid">19892189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Gallagher</surname><given-names>S</given-names></name></person-group><article-title>Immunoblotting and immunodetection</article-title><source>Curr Protoc Mol Biol</source><year>2016</year><volume>114</volume><issue>8</issue><fpage>1</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1002/0471142727.mb1008s114</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Ni D, Xu P, Gallagher S (2016) Immunoblotting and immunodetection. Curr Protoc Mol Biol 114(8):1&#x02013;37. 10.1002/0471142727.mb1008s114</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CEP</given-names></name><name><surname>Prasad</surname><given-names>V</given-names></name></person-group><article-title>Targeted cancer therapies</article-title><source>Am Fam Physician</source><year>2021</year><volume>103</volume><issue>3</issue><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">33507053</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Smith CEP, Prasad V (2021) Targeted cancer therapies. Am Fam Physician 103(3):155&#x02013;163<pub-id pub-id-type="pmid">33507053</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>JH</given-names></name><name><surname>Chan</surname><given-names>LC</given-names></name><name><surname>Song</surname><given-names>MS</given-names></name><name><surname>Hung</surname><given-names>MC</given-names></name></person-group><article-title>New approaches on cancer immunotherapy</article-title><source>Cold Spring Harb Perspect Med</source><year>2020</year><volume>10</volume><issue>8</issue><fpage>36863</fpage><lpage>36879</lpage><pub-id pub-id-type="doi">10.1101/cshperspect.a036863</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Cha JH, Chan LC, Song MS, Hung MC (2020) New approaches on cancer immunotherapy. Cold Spring Harb Perspect Med 10(8):36863&#x02013;36879. 10.1101/cshperspect.a036863</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Keam</surname><given-names>SJ</given-names></name></person-group><article-title>Trastuzumab deruxtecan: first approval</article-title><source>Drugs</source><year>2020</year><volume>80</volume><issue>5</issue><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1007/s40265-020-01281-4</pub-id><pub-id pub-id-type="pmid">32144719</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Keam SJ (2020) Trastuzumab deruxtecan: first approval. Drugs 80(5):501&#x02013;508. 10.1007/s40265-020-01281-4<pub-id pub-id-type="pmid">32144719</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>A</given-names></name><name><surname>Salman</surname><given-names>B</given-names></name><name><surname>Shaikh</surname><given-names>AJ</given-names></name></person-group><article-title>Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: a comprehensive review</article-title><source>J Oncol Pharm Pract</source><year>2024</year><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1177/10781552241252100</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Mohamed A, Salman B, Shaikh AJ (2024) Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: a comprehensive review. J Oncol Pharm Pract 6:1&#x02013;11. 10.1177/10781552241252100</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Antibody drug conjugate: The "biological missile" for targeted cancer therapy</article-title><source>Signal Transduct Target Ther</source><year>2022</year><volume>7</volume><issue>1</issue><fpage>93</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1038/s41392-022-00947-7</pub-id><pub-id pub-id-type="pmid">35318309</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Fu Z, Li S, Han S, Shi C, Zhang Y (2022) Antibody drug conjugate: The &#x0201c;biological missile&#x0201d; for targeted cancer therapy. Signal Transduct Target Ther 7(1):93&#x02013;118. 10.1038/s41392-022-00947-7<pub-id pub-id-type="pmid">35318309</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>de Assis</surname><given-names>LH</given-names></name><name><surname>Fassi</surname><given-names>DE</given-names></name><name><surname>Hutchings</surname><given-names>M</given-names></name></person-group><article-title>Bispecific antibody therapies</article-title><source>Hematology Am Soc Hematol Educ Program</source><year>2023</year><volume>1</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1182/hematology.2023000508</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">de Assis LH, Fassi DE, Hutchings M (2023) Bispecific antibody therapies. Hematology Am Soc Hematol Educ Program 1:216&#x02013;222. 10.1182/hematology.2023000508</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>CRC</given-names></name><name><surname>Abdul-Majeed</surname><given-names>S</given-names></name><name><surname>Cael</surname><given-names>B</given-names></name><name><surname>Barta</surname><given-names>SK</given-names></name></person-group><article-title>Clinical pharmacokinetics and pharmacodynamics of bortezomib</article-title><source>Clin Pharmacokinet</source><year>2019</year><volume>58</volume><issue>2</issue><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1007/s40262-018-0679-9</pub-id><pub-id pub-id-type="pmid">29802543</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Tan CRC, Abdul-Majeed S, Cael B, Barta SK (2019) Clinical pharmacokinetics and pharmacodynamics of bortezomib. Clin Pharmacokinet 58(2):157&#x02013;168. 10.1007/s40262-018-0679-9<pub-id pub-id-type="pmid">29802543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Pekkle</surname><given-names>HY</given-names></name><name><surname>Liang</surname><given-names>TR</given-names></name><name><surname>Jiang</surname><given-names>SJ</given-names></name><name><surname>Peng</surname><given-names>SY</given-names></name></person-group><article-title><italic>Schistosoma mansoni</italic> soluble egg antigen suppresses colorectal cancer growth in vitro and in vivo</article-title><source>J Microbiol Immunol Infect</source><year>2024</year><volume>58</volume><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2024.11.009</pub-id><pub-id pub-id-type="pmid">39653602</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Pekkle HY, Liang TR, Jiang SJ, Peng SY (2024) <italic>Schistosoma mansoni</italic> soluble egg antigen suppresses colorectal cancer growth in vitro and in vivo. J Microbiol Immunol Infect 58:241&#x02013;250. 10.1016/j.jmii.2024.11.009<pub-id pub-id-type="pmid">39653602</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title><italic>Plasmodium</italic> infection suppresses colon cancer growth by inhibiting proliferation and promoting apoptosis associated with disrupting mitochondrial biogenesis and mitophagy in mice</article-title><source>Parasit Vectors</source><year>2022</year><volume>15</volume><issue>1</issue><fpage>192</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1186/s13071-022-05291-x</pub-id><pub-id pub-id-type="pmid">35668501</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Yao X, Cao Y, Lu L, Xu Y, Chen H, Liu C et al (2022) <italic>Plasmodium</italic> infection suppresses colon cancer growth by inhibiting proliferation and promoting apoptosis associated with disrupting mitochondrial biogenesis and mitophagy in mice. Parasit Vectors 15(1):192&#x02013;204. 10.1186/s13071-022-05291-x<pub-id pub-id-type="pmid">35668501</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>S</given-names></name><name><surname>Hao</surname><given-names>C</given-names></name><name><surname>Zhan</surname><given-names>B</given-names></name><name><surname>Zhuang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title><italic>Trichinella spiralis</italic> calreticulin S-domain binds to human complement C1q to interfere with C1q-mediated immune functions</article-title><source>Front Immunol</source><year>2020</year><volume>11</volume><fpage>572326</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.572326</pub-id><pub-id pub-id-type="pmid">33329535</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Shao S, Hao C, Zhan B, Zhuang Q, Zhao L, Chen Y et al (2020) <italic>Trichinella spiralis</italic> calreticulin S-domain binds to human complement C1q to interfere with C1q-mediated immune functions. Front Immunol 11:572326. 10.3389/fimmu.2020.572326<pub-id pub-id-type="pmid">33329535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>SN</given-names></name><name><surname>Emmerich</surname><given-names>PB</given-names></name><name><surname>Davis</surname><given-names>NM</given-names></name><name><surname>Deming</surname><given-names>DA</given-names></name><name><surname>Knoll</surname><given-names>LJ</given-names></name></person-group><article-title>Novel murine pancreatic tumor model demonstrates immunotherapeutic control of tumor progression by a <italic>Toxoplasma gondii</italic> protein</article-title><source>Infect Immun</source><year>2021</year><volume>89</volume><issue>12</issue><fpage>e0050821</fpage><pub-id pub-id-type="doi">10.1128/iai.00508-21</pub-id><pub-id pub-id-type="pmid">34543124</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Payne SN, Emmerich PB, Davis NM, Deming DA, Knoll LJ (2021) Novel murine pancreatic tumor model demonstrates immunotherapeutic control of tumor progression by a <italic>Toxoplasma gondii</italic> protein. Infect Immun 89(12):e0050821. 10.1128/iai.00508-21<pub-id pub-id-type="pmid">34543124</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>CG</given-names></name><name><surname>Balu</surname><given-names>KE</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Rychahou</surname><given-names>P</given-names></name><name><surname>Izumi</surname><given-names>T</given-names></name><etal/></person-group><article-title>A novel protozoa parasite-derived protein adjuvant is effective in immunization with cancer cells to activate the cancer-specific protective immunity and inhibit the cancer growth in a murine model of colorectal cancer</article-title><source>Cells</source><year>2024</year><volume>13</volume><issue>2</issue><fpage>111</fpage><pub-id pub-id-type="doi">10.3390/cells13020111</pub-id><pub-id pub-id-type="pmid">38247803</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Mani R, Martin CG, Balu KE, Wang Q, Rychahou P, Izumi T et al (2024) A novel protozoa parasite-derived protein adjuvant is effective in immunization with cancer cells to activate the cancer-specific protective immunity and inhibit the cancer growth in a murine model of colorectal cancer. Cells 13(2):111. 10.3390/cells13020111<pub-id pub-id-type="pmid">38247803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title><italic>Neospora caninum</italic> inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model</article-title><source>Parasit Vectors</source><year>2022</year><volume>15</volume><issue>1</issue><fpage>332</fpage><pub-id pub-id-type="doi">10.1186/s13071-022-05456-8</pub-id><pub-id pub-id-type="pmid">36138417</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Li X, Qi M, He K, Liu H, Yan W, Zhao L et al (2022) <italic>Neospora caninum</italic> inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model. Parasit Vectors 15(1):332. 10.1186/s13071-022-05456-8<pub-id pub-id-type="pmid">36138417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Maravelez</surname><given-names>AVA</given-names></name><name><surname>Cris&#x000f3;stomo</surname><given-names>VMDP</given-names></name><name><surname>Eligio</surname><given-names>GL</given-names></name><name><surname>Franco</surname><given-names>LO</given-names></name><name><surname>Castro</surname><given-names>PD</given-names></name><name><surname>Pati&#x000f1;o</surname><given-names>LG</given-names></name><etal/></person-group><article-title>Tumor-suppressive cross-linking of anti-<italic>T. cruzi</italic> antibodies in acute lymphoblastic leukemia</article-title><source>Int J Mol Sci</source><year>2024</year><volume>25</volume><issue>15</issue><fpage>8307</fpage><lpage>8324</lpage><pub-id pub-id-type="doi">10.3390/ijms25158307</pub-id><pub-id pub-id-type="pmid">39125875</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Maravelez AVA, Cris&#x000f3;stomo VMDP, Eligio GL, Franco LO, Castro PD, Pati&#x000f1;o LG et al (2024) Tumor-suppressive cross-linking of anti-<italic>T. cruzi</italic> antibodies in acute lymphoblastic leukemia. Int J Mol Sci 25(15):8307&#x02013;8324. 10.3390/ijms25158307<pub-id pub-id-type="pmid">39125875</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>TT</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Lu</surname><given-names>XY</given-names></name><name><surname>Wang</surname><given-names>XC</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and <italic>Trichinella spiralis</italic></article-title><source>Parasit Vectors</source><year>2021</year><volume>14</volume><issue>1</issue><fpage>498</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1186/s13071-021-05008-6</pub-id><pub-id pub-id-type="pmid">34565443</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Yue TT, Zhang N, Li JH, Lu XY, Wang XC, Li X et al (2021) Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and <italic>Trichinella spiralis</italic>. Parasit Vectors 14(1):498&#x02013;511. 10.1186/s13071-021-05008-6<pub-id pub-id-type="pmid">34565443</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliamonte</surname><given-names>M</given-names></name><name><surname>Cavalluzzo</surname><given-names>B</given-names></name><name><surname>Mauriello</surname><given-names>A</given-names></name><name><surname>Ragone</surname><given-names>C</given-names></name><name><surname>Buonaguro</surname><given-names>FM</given-names></name><name><surname>Tornesello</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Molecular mimicry and cancer vaccine development</article-title><source>Mol Cancer</source><year>2023</year><volume>22</volume><issue>1</issue><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1186/s12943-023-01776-0</pub-id><pub-id pub-id-type="pmid">37101139</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro FM, Tornesello ML et al (2023) Molecular mimicry and cancer vaccine development. Mol Cancer 22(1):75&#x02013;87. 10.1186/s12943-023-01776-0<pub-id pub-id-type="pmid">37101139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Nan</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification and characterization of myeloma-associated antigens in <italic>Trichinella spiralis</italic></article-title><source>Exp Parasitol</source><year>2011</year><volume>127</volume><issue>4</issue><fpage>784</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2010.12.001</pub-id><pub-id pub-id-type="pmid">21232537</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Gong P, Zhang J, Cao L, Nan Z, Li J, Yang J et al (2011) Identification and characterization of myeloma-associated antigens in <italic>Trichinella spiralis</italic>. Exp Parasitol 127(4):784&#x02013;788. 10.1016/j.exppara.2010.12.001<pub-id pub-id-type="pmid">21232537</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Lv</surname><given-names>Q</given-names></name><name><surname>Gong</surname><given-names>PT</given-names></name><name><surname>Su</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Identification of a novel gene product expressed by <italic>Trichinella spiralis</italic> that binds antiserum to Sp2/0 myeloma cells</article-title><source>Vet Parasitol</source><year>2013</year><volume>194</volume><issue>2&#x02013;4</issue><fpage>183</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2013.01.051</pub-id><pub-id pub-id-type="pmid">23465747</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Duan L, Li J, Cheng B, Lv Q, Gong PT, Su LB et al (2013) Identification of a novel gene product expressed by <italic>Trichinella spiralis</italic> that binds antiserum to Sp2/0 myeloma cells. Vet Parasitol 194(2&#x02013;4):183&#x02013;185. 10.1016/j.vetpar.2013.01.051<pub-id pub-id-type="pmid">23465747</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Prokaryotic expression and identification of sHSP genes for antigens associated with Lewis lung cancer (LLC) cells and <italic>Trichinella spiralis</italic></article-title><source>J Pathog</source><year>2019</year><volume>14</volume><fpage>409</fpage><lpage>412</lpage></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Lu X, Zhang X, Li S, Zhang H, Gong P, Li J et al (2019) Prokaryotic expression and identification of sHSP genes for antigens associated with Lewis lung cancer (LLC) cells and <italic>Trichinella spiralis</italic>. J Pathog 14:409&#x02013;412</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Screening of A549 cells-associated scFv antibody against <italic>Trichinella spiralis</italic> antigen protein 7TR</article-title><source>Chin J Biol</source><year>2017</year><volume>30</volume><fpage>488</fpage><lpage>493</lpage></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Wang J, Zhang G, Zhang H, Lu X, Gong P, Li J et al (2017) Screening of A549 cells-associated scFv antibody against <italic>Trichinella spiralis</italic> antigen protein 7TR. Chin J Biol 30:488&#x02013;493</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>B</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification of the differentially expressed genes in SP2/0 myeloma cells from Balb/c mice infected with <italic>Trichinella spiralis</italic></article-title><source>Vet Parasitol</source><year>2013</year><volume>194</volume><issue>2&#x02013;4</issue><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2013.01.050</pub-id><pub-id pub-id-type="pmid">23473833</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Deng B, Gong P, Li J, Cheng B, Ren W, Yang J et al (2013) Identification of the differentially expressed genes in SP2/0 myeloma cells from Balb/c mice infected with <italic>Trichinella spiralis</italic>. Vet Parasitol 194(2&#x02013;4):179&#x02013;182. 10.1016/j.vetpar.2013.01.050<pub-id pub-id-type="pmid">23473833</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>FE</given-names></name><name><surname>Raso</surname><given-names>P</given-names></name><name><surname>Coelho</surname><given-names>PM</given-names></name></person-group><article-title>Evolution of sarcoma 180 (ascitic tumor) in mice infected with <italic>Schistosoma mansoni</italic></article-title><source>Rev Soc Bras Med Trop</source><year>1986</year><volume>19</volume><issue>1</issue><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1590/s0037-86821986000100009</pub-id><pub-id pub-id-type="pmid">3120251</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Pereira FE, Raso P, Coelho PM (1986) Evolution of sarcoma 180 (ascitic tumor) in mice infected with <italic>Schistosoma mansoni</italic>. Rev Soc Bras Med Trop 19(1):39&#x02013;42. 10.1590/s0037-86821986000100009<pub-id pub-id-type="pmid">3120251</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Loures</surname><given-names>MA</given-names></name><name><surname>Andrade</surname><given-names>A</given-names></name><name><surname>Peralta</surname><given-names>JM</given-names></name></person-group><article-title>Local response in mouse tumor treated with <italic>Schistosoma mansoni</italic> antigen</article-title><source>Mem Inst Oswaldo Cruz</source><year>1991</year><volume>86</volume><issue>3</issue><fpage>127</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1590/s0074-02761991000700027</pub-id><pub-id pub-id-type="pmid">1668995</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Loures MA, Andrade A, Peralta JM (1991) Local response in mouse tumor treated with <italic>Schistosoma mansoni</italic> antigen. Mem Inst Oswaldo Cruz 86(3):127&#x02013;128. 10.1590/s0074-02761991000700027<pub-id pub-id-type="pmid">1668995</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>El Skhawy</surname><given-names>N</given-names></name><name><surname>Eissa</surname><given-names>MM</given-names></name></person-group><article-title>Shedding light on a mysterious link between <italic>Toxoplasma gondii</italic> and cancer: a review</article-title><source>Exp Parasitol</source><year>2023</year><volume>250</volume><fpage>108544</fpage><lpage>108552</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2023.108544</pub-id><pub-id pub-id-type="pmid">37149210</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">El Skhawy N, Eissa MM (2023) Shedding light on a mysterious link between <italic>Toxoplasma gondii</italic> and cancer: a review. Exp Parasitol 250:108544&#x02013;108552. 10.1016/j.exppara.2023.108544<pub-id pub-id-type="pmid">37149210</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="other">El Skhawy NF (2022) Antineoplastic activity of <italic>Toxoplasma gondii</italic> antigen on MCF-7 human breast cancer cell line and Ehrlich solid carcinoma model. Thesis, MD PhD. Medical Parasitology, University of Alexandria, Faculty of Medicine 2022</mixed-citation></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>F</given-names></name><name><surname>Farahbakhsh</surname><given-names>Z</given-names></name><name><surname>Balouti</surname><given-names>A</given-names></name><name><surname>Kalantari</surname><given-names>R</given-names></name><name><surname>Pourshahbazi</surname><given-names>G</given-names></name><name><surname>Mobarakeh</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Human anti-<italic>Toxoplasma</italic> antibodies attach strongly to breast cancer cells</article-title><source>Int J Cancer Manag</source><year>2023</year><volume>16</volume><issue>1</issue><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.5812/ijcm-135924</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Hosseini F, Farahbakhsh Z, Balouti A, Kalantari R, Pourshahbazi G, Mobarakeh SM et al (2023) Human anti-<italic>Toxoplasma</italic> antibodies attach strongly to breast cancer cells. Int J Cancer Manag 16(1):183&#x02013;188</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>YTM</given-names></name><name><surname>Sibley</surname><given-names>L</given-names></name><name><surname>Przanowski</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>XY</given-names></name><name><surname>Kovacs</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title><italic>Toxoplasma gondii</italic> infection supports the infiltration of T cells into brain tumors</article-title><source>J Neuroimmunol</source><year>2024</year><volume>393</volume><fpage>578402</fpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2024.578402</pub-id><pub-id pub-id-type="pmid">38996717</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Nguyen YTM, Sibley L, Przanowski P, Zhao XY, Kovacs M, Wang S et al (2024) <italic>Toxoplasma gondii</italic> infection supports the infiltration of T cells into brain tumors. J Neuroimmunol 393:578402. 10.1016/j.jneuroim.2024.578402<pub-id pub-id-type="pmid">38996717</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>ZQ</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>LX</given-names></name></person-group><article-title>Impact of <italic>Toxoplasma gondii</italic> on the proliferation and apoptosis of tumor cell lines</article-title><source>Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi</source><year>2012</year><volume>30</volume><issue>2</issue><fpage>157</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">22908820</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Wu X, Sun L, Zhang L, Liu ZQ, Luo Q, Zhang LX (2012) Impact of <italic>Toxoplasma gondii</italic> on the proliferation and apoptosis of tumor cell lines. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 30(2):157&#x02013;159<pub-id pub-id-type="pmid">22908820</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>MM</given-names></name><name><surname>Gaafar</surname><given-names>MR</given-names></name><name><surname>Younis</surname><given-names>LK</given-names></name><name><surname>Ismail</surname><given-names>CA</given-names></name><name><surname>El Skhawy</surname><given-names>N</given-names></name></person-group><article-title>Evaluation of cytotoxic activity of live <italic>Toxoplasma gondii</italic> tachyzoites and toxoplasma antigen on MCF-7 human breast cancer cell line</article-title><source>EUREKA: Life Sci</source><year>2022</year><volume>2</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.21303/2504-5695.2022.002409</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Eissa MM, Gaafar MR, Younis LK, Ismail CA, El Skhawy N (2022) Evaluation of cytotoxic activity of live <italic>Toxoplasma gondii</italic> tachyzoites and toxoplasma antigen on MCF-7 human breast cancer cell line. EUREKA: Life Sci 2:45&#x02013;50. 10.21303/2504-5695.2022.002409</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>F</given-names></name><etal/></person-group><article-title><italic>Toxoplasma gondii</italic> suppresses proliferation and migration of breast cancer cells by regulating their transcriptome</article-title><source>Cancer Cell Int</source><year>2024</year><volume>24</volume><issue>1</issue><fpage>144</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1186/s12935-024-03333-1</pub-id><pub-id pub-id-type="pmid">38654350</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Ye H, Zhou X, Zhu B, Xiong T, Huang W, He F et al (2024) <italic>Toxoplasma gondii</italic> suppresses proliferation and migration of breast cancer cells by regulating their transcriptome. Cancer Cell Int 24(1):144&#x02013;158. 10.1186/s12935-024-03333-1<pub-id pub-id-type="pmid">38654350</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>JR</given-names></name><name><surname>Byrne</surname><given-names>KT</given-names></name><name><surname>Lizotte</surname><given-names>PH</given-names></name><name><surname>Toraya-Brown</surname><given-names>S</given-names></name><name><surname>Scarlett</surname><given-names>UK</given-names></name><name><surname>Alexander</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated <italic>Toxoplasma gondii</italic> protects against rechallenge</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><issue>1</issue><fpage>469</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1201209</pub-id><pub-id pub-id-type="pmid">23225891</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP et al (2013) Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated <italic>Toxoplasma gondii</italic> protects against rechallenge. J Immunol 190(1):469&#x02013;478. 10.4049/jimmunol.1201209<pub-id pub-id-type="pmid">23225891</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>KL</given-names></name><name><surname>Fox</surname><given-names>BA</given-names></name><name><surname>Bzik</surname><given-names>DJ</given-names></name></person-group><article-title>Attenuated <italic>Toxoplasma gondii</italic> stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations</article-title><source>Cancer Immunol Res</source><year>2015</year><volume>3</volume><issue>8</issue><fpage>891</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.Cir-14-0235</pub-id><pub-id pub-id-type="pmid">25804437</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Sanders KL, Fox BA, Bzik DJ (2015) Attenuated <italic>Toxoplasma gondii</italic> stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations. Cancer Immunol Res 3(8):891&#x02013;901. 10.1158/2326-6066.Cir-14-0235<pub-id pub-id-type="pmid">25804437</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>JR</given-names></name><name><surname>Fox</surname><given-names>BA</given-names></name><name><surname>Sanders</surname><given-names>KL</given-names></name><name><surname>Lizotte</surname><given-names>PH</given-names></name><name><surname>Cubillos-Ruiz</surname><given-names>JR</given-names></name><name><surname>Scarlett</surname><given-names>UK</given-names></name><etal/></person-group><article-title>Avirulent <italic>Toxoplasma gondii</italic> generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment</article-title><source>Cancer Res</source><year>2013</year><volume>73</volume><issue>13</issue><fpage>3842</fpage><lpage>3851</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.Can-12-1974</pub-id><pub-id pub-id-type="pmid">23704211</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Baird JR, Fox BA, Sanders KL, Lizotte PH, Cubillos-Ruiz JR, Scarlett UK et al (2013) Avirulent <italic>Toxoplasma gondii</italic> generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res 73(13):3842&#x02013;3851. 10.1158/0008-5472.Can-12-1974<pub-id pub-id-type="pmid">23704211</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Hafez</surname><given-names>EN</given-names></name><name><surname>Youssef</surname><given-names>HMG</given-names></name><name><surname>El-Kabany</surname><given-names>HA</given-names></name></person-group><article-title>Vaccination with gamma radiation-attenuated <italic>Toxoplasma gondii</italic> protects against ovarian infiltration in mice-bearing Ehrlich ascites carcinoma</article-title><source>Int J Radiat Biol</source><year>2020</year><volume>96</volume><issue>6</issue><fpage>814</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1080/09553002.2020.1739772</pub-id><pub-id pub-id-type="pmid">32149560</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Hafez EN, Youssef HMG, El-Kabany HA (2020) Vaccination with gamma radiation-attenuated <italic>Toxoplasma gondii</italic> protects against ovarian infiltration in mice-bearing Ehrlich ascites carcinoma. Int J Radiat Biol 96(6):814&#x02013;822. 10.1080/09553002.2020.1739772<pub-id pub-id-type="pmid">32149560</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Pyo</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>YW</given-names></name><name><surname>Lim</surname><given-names>SM</given-names></name><name><surname>Shin</surname><given-names>EH</given-names></name></person-group><article-title>Immune adjuvant effect of a <italic>Toxoplasma gondii</italic> profilin-like protein in autologous whole-tumor-cell vaccination in mice</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><issue>45</issue><fpage>74107</fpage><lpage>74119</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.12316</pub-id><pub-id pub-id-type="pmid">27687589</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Pyo KH, Lee YW, Lim SM, Shin EH (2016) Immune adjuvant effect of a <italic>Toxoplasma gondii</italic> profilin-like protein in autologous whole-tumor-cell vaccination in mice. Oncotarget 7(45):74107&#x02013;74119. 10.18632/oncotarget.12316<pub-id pub-id-type="pmid">27687589</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YC</given-names></name><name><surname>Elsheikha</surname><given-names>HM</given-names></name><name><surname>Wang</surname><given-names>JH</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>JJ</given-names></name><name><surname>Zhu</surname><given-names>XQ</given-names></name><etal/></person-group><article-title>Synergy between <italic>Toxoplasma gondii</italic> type I &#x00394;GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors</article-title><source>J Immunother Cancer</source><year>2021</year><volume>9</volume><issue>11</issue><fpage>e002970</fpage><pub-id pub-id-type="doi">10.1136/jitc-2021-002970</pub-id><pub-id pub-id-type="pmid">34725213</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Zhu YC, Elsheikha HM, Wang JH, Fang S, He JJ, Zhu XQ et al (2021) Synergy between <italic>Toxoplasma gondii</italic> type I &#x00394;GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer 9(11):e002970. 10.1136/jitc-2021-002970<pub-id pub-id-type="pmid">34725213</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Altun</surname><given-names>A</given-names></name><name><surname>Saraydin</surname><given-names>SU</given-names></name><name><surname>Soylu</surname><given-names>S</given-names></name><name><surname>Inan</surname><given-names>DS</given-names></name><name><surname>Yasti</surname><given-names>C</given-names></name><name><surname>Ozdenkaya</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Chemopreventive effects of hydatid disease on experimental breast cancer</article-title><source>Asian Pac J Cancer Prev</source><year>2015</year><volume>16</volume><issue>4</issue><fpage>1391</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.7314/apjcp.2015.16.4.1391</pub-id><pub-id pub-id-type="pmid">25743804</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Altun A, Saraydin SU, Soylu S, Inan DS, Yasti C, Ozdenkaya Y et al (2015) Chemopreventive effects of hydatid disease on experimental breast cancer. Asian Pac J Cancer Prev 16(4):1391&#x02013;1395. 10.7314/apjcp.2015.16.4.1391<pub-id pub-id-type="pmid">25743804</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Berriel</surname><given-names>E</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Monin</surname><given-names>L</given-names></name><name><surname>Festari</surname><given-names>MF</given-names></name><name><surname>Berois</surname><given-names>N</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>G</given-names></name><etal/></person-group><article-title>Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer</article-title><source>Sci World J</source><year>2013</year><volume>2013</volume><fpage>230176</fpage><lpage>230183</lpage><pub-id pub-id-type="doi">10.1155/2013/230176</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Berriel E, Russo S, Monin L, Festari MF, Berois N, Fern&#x000e1;ndez G et al (2013) Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. Sci World J 2013:230176&#x02013;230183. 10.1155/2013/230176</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">Hajizadeh M, Amni F, Sahlolbei M, Tavakoli-yaraki M, Mamaghani AJ, Sefiddashti RR, et al. (2021) Antigen similarity in hydatid cyst wall and human bone tumours: a short report</mixed-citation></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamadi</surname><given-names>F</given-names></name><name><surname>Shakibapour</surname><given-names>M</given-names></name><name><surname>Sharafi</surname><given-names>SM</given-names></name><name><surname>Andalib</surname><given-names>AR</given-names></name><name><surname>Tolouei</surname><given-names>S</given-names></name><name><surname>Yousofi-Darani</surname><given-names>H</given-names></name></person-group><article-title>Investigating the reaction of antisera against hydatid cyst antigens with the surface of breast cancer (4T1), melanoma (B16F10), and normal spleen cells using flow cytometry technique</article-title><source>J of Isfahan Med Sch</source><year>2018</year><volume>36</volume><issue>499</issue><fpage>1191</fpage><lpage>1196</lpage></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Mohamadi F, Shakibapour M, Sharafi SM, Andalib AR, Tolouei S, Yousofi-Darani H (2018) Investigating the reaction of antisera against hydatid cyst antigens with the surface of breast cancer (4T1), melanoma (B16F10), and normal spleen cells using flow cytometry technique. J of Isfahan Med Sch 36(499):1191&#x02013;1196</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Shakibapour</surname><given-names>M</given-names></name><name><surname>Kefayat</surname><given-names>A</given-names></name><name><surname>Reza Mofid</surname><given-names>M</given-names></name><name><surname>Shojaie</surname><given-names>B</given-names></name><name><surname>Mohamadi</surname><given-names>F</given-names></name><name><surname>Maryam Sharafi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model</article-title><source>Int Immunopharmacol</source><year>2021</year><volume>99</volume><fpage>107955</fpage><lpage>107965</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2021.107955</pub-id><pub-id pub-id-type="pmid">34247052</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Shakibapour M, Kefayat A, Reza Mofid M, Shojaie B, Mohamadi F, Maryam Sharafi S et al (2021) Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model. Int Immunopharmacol 99:107955&#x02013;107965. 10.1016/j.intimp.2021.107955<pub-id pub-id-type="pmid">34247052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharafi</surname><given-names>SM</given-names></name><name><surname>Shirzad</surname><given-names>H</given-names></name><name><surname>Khanahmad</surname><given-names>H</given-names></name><name><surname>Ataei</surname><given-names>B</given-names></name><name><surname>Darani</surname><given-names>HY</given-names></name></person-group><article-title>Monoclonal antibodies production against a 40Kda band of hydatid cyst fluid</article-title><source>Recent Pat Biotechnol</source><year>2018</year><volume>12</volume><issue>1</issue><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.2174/1872208311666170317151346</pub-id><pub-id pub-id-type="pmid">28317492</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Sharafi SM, Shirzad H, Khanahmad H, Ataei B, Darani HY (2018) Monoclonal antibodies production against a 40Kda band of hydatid cyst fluid. Recent Pat Biotechnol 12(1):57&#x02013;64. 10.2174/1872208311666170317151346<pub-id pub-id-type="pmid">28317492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharafi</surname><given-names>SM</given-names></name><name><surname>Rafiei</surname><given-names>R</given-names></name><name><surname>Hadipour</surname><given-names>M</given-names></name><name><surname>Shirzad</surname><given-names>H</given-names></name><name><surname>Khanahmad</surname><given-names>H</given-names></name><name><surname>Darani</surname><given-names>HY</given-names></name></person-group><article-title>A nonglycosylated 27 kDa molecule as common antigen between human breast cancer and <italic>Echinococcus granulosus</italic> hydatid cyst wall</article-title><source>Adv Breast Cancer Res</source><year>2016</year><volume>5</volume><issue>2</issue><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.4236/abcr.2016.52010</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Sharafi SM, Rafiei R, Hadipour M, Shirzad H, Khanahmad H, Darani HY (2016) A nonglycosylated 27 kDa molecule as common antigen between human breast cancer and <italic>Echinococcus granulosus</italic> hydatid cyst wall. Adv Breast Cancer Res 5(2):90&#x02013;95</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Daneshpour</surname><given-names>S</given-names></name><name><surname>Bahadoran</surname><given-names>M</given-names></name><name><surname>Hejazi</surname><given-names>SH</given-names></name><name><surname>Eskandarian</surname><given-names>AA</given-names></name><name><surname>Mahmoudzadeh</surname><given-names>M</given-names></name><name><surname>Darani</surname><given-names>HY</given-names></name></person-group><article-title>Common antigens between hydatid cyst and cancers</article-title><source>Adv Biomed Res</source><year>2016</year><volume>5</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.4103/2277-9175.175242</pub-id><pub-id pub-id-type="pmid">26962511</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Daneshpour S, Bahadoran M, Hejazi SH, Eskandarian AA, Mahmoudzadeh M, Darani HY (2016) Common antigens between hydatid cyst and cancers. Adv Biomed Res 5:9&#x02013;13. 10.4103/2277-9175.175242<pub-id pub-id-type="pmid">26962511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Shakibapour</surname><given-names>M</given-names></name><name><surname>Shojaie</surname><given-names>B</given-names></name><name><surname>Yousofi</surname><given-names>DH</given-names></name></person-group><article-title>Immunization with hydatid cyst wall antigens can inhibit breast cancer through changes in serum levels of Th1/Th2 cytokines</article-title><source>Int J Prev Med</source><year>2020</year><volume>11</volume><fpage>189</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.4103/ijpvm.IJPVM_311_19</pub-id><pub-id pub-id-type="pmid">33815713</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Shakibapour M, Shojaie B, Yousofi DH (2020) Immunization with hydatid cyst wall antigens can inhibit breast cancer through changes in serum levels of Th1/Th2 cytokines. Int J Prev Med 11:189&#x02013;196. 10.4103/ijpvm.IJPVM_311_19<pub-id pub-id-type="pmid">33815713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>WK</given-names></name><name><surname>Heath</surname><given-names>DD</given-names></name><name><surname>Savage</surname><given-names>T</given-names></name></person-group><article-title>Possible antigenic similarity between pulmonary carcinoma and cysts of <italic>Echinococcus granulosus</italic></article-title><source>Br Med J</source><year>1979</year><volume>1</volume><issue>6176</issue><fpage>1463</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.6176.1463-a</pub-id><pub-id pub-id-type="pmid">466062</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Yong WK, Heath DD, Savage T (1979) Possible antigenic similarity between pulmonary carcinoma and cysts of <italic>Echinococcus granulosus</italic>. Br Med J 1(6176):1463&#x02013;1464. 10.1136/bmj.1.6176.1463-a<pub-id pub-id-type="pmid">466062</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>Rostamirad</surname><given-names>S</given-names></name><name><surname>Daneshpour</surname><given-names>S</given-names></name><name><surname>Mofid</surname><given-names>MR</given-names></name><name><surname>Andalib</surname><given-names>A</given-names></name><name><surname>Eskandariyan</surname><given-names>A</given-names></name><name><surname>Mousavi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inhibition of mouse colon cancer growth following immunotherapy with a fraction of hydatid cyst fluid</article-title><source>Exp Parasitol</source><year>2023</year><volume>249</volume><fpage>108501</fpage><lpage>108507</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2023.108501</pub-id><pub-id pub-id-type="pmid">36931383</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">Rostamirad S, Daneshpour S, Mofid MR, Andalib A, Eskandariyan A, Mousavi S et al (2023) Inhibition of mouse colon cancer growth following immunotherapy with a fraction of hydatid cyst fluid. Exp Parasitol 249:108501&#x02013;108507. 10.1016/j.exppara.2023.108501<pub-id pub-id-type="pmid">36931383</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel Rahman</surname><given-names>MMI</given-names></name></person-group><article-title>Morphological and molecular characterization of <italic>Setaria equina</italic> in donkeys</article-title><source>Beni-Suef Univ J Basic Appl Sci</source><year>2020</year><volume>9</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/s43088-020-00046-y</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Abdel Rahman MMI (2020) Morphological and molecular characterization of <italic>Setaria equina</italic> in donkeys. Beni-Suef Univ J Basic Appl Sci 9:1&#x02013;8</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Latif</surname><given-names>M</given-names></name><name><surname>Sakran</surname><given-names>T</given-names></name></person-group><article-title>Detection for cross-reactive proteins in filarial worm <italic>Setaria equina</italic>, MCF-7 human breast cancer, and Huh-7 hepatoma cells</article-title><source>J Immunoassay Immunochem</source><year>2016</year><volume>37</volume><issue>6</issue><fpage>572</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1080/15321819.2016.1179644</pub-id><pub-id pub-id-type="pmid">27093573</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Abdel-Latif M, Sakran T (2016) Detection for cross-reactive proteins in filarial worm <italic>Setaria equina</italic>, MCF-7 human breast cancer, and Huh-7 hepatoma cells. J Immunoassay Immunochem 37(6):572&#x02013;584. 10.1080/15321819.2016.1179644<pub-id pub-id-type="pmid">27093573</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Latif</surname><given-names>M</given-names></name><name><surname>Sakran</surname><given-names>T</given-names></name><name><surname>El-Shahawi</surname><given-names>G</given-names></name><name><surname>El-Fayoumi</surname><given-names>H</given-names></name><name><surname>El-Mallah</surname><given-names>AM</given-names></name></person-group><article-title>Immunomodulatory effect of diethylcarbamazine citrate plus filarial excretory-secretory product on rat hepatocarcinogenesis</article-title><source>Int Immunopharmacol</source><year>2015</year><volume>24</volume><issue>2</issue><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.12.004</pub-id><pub-id pub-id-type="pmid">25499729</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Abdel-Latif M, Sakran T, El-Shahawi G, El-Fayoumi H, El-Mallah AM (2015) Immunomodulatory effect of diethylcarbamazine citrate plus filarial excretory-secretory product on rat hepatocarcinogenesis. Int Immunopharmacol 24(2):173&#x02013;181. 10.1016/j.intimp.2014.12.004<pub-id pub-id-type="pmid">25499729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Latif</surname><given-names>M</given-names></name><name><surname>Sakran</surname><given-names>T</given-names></name><name><surname>El-Shahawi</surname><given-names>G</given-names></name><name><surname>El-Fayoumi</surname><given-names>H</given-names></name><name><surname>El-Mallah</surname><given-names>AM</given-names></name></person-group><article-title>Effect of diethylcarbamazine citrate and <italic>Setaria equina</italic> excretory-secretory material on rat hepatocellular carcinoma</article-title><source>Arch Immunol Ther Exp</source><year>2014</year><volume>62</volume><issue>6</issue><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1007/s00005-014-0292-z</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Abdel-Latif M, Sakran T, El-Shahawi G, El-Fayoumi H, El-Mallah AM (2014) Effect of diethylcarbamazine citrate and <italic>Setaria equina</italic> excretory-secretory material on rat hepatocellular carcinoma. Arch Immunol Ther Exp 62(6):511&#x02013;520. 10.1007/s00005-014-0292-z</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheklakova</surname><given-names>LA</given-names></name><name><surname>Kallinikova</surname><given-names>VD</given-names></name><name><surname>Karpenko</surname><given-names>LP</given-names></name></person-group><article-title>Genetic heterogeneity of <italic>Trypanosoma cruzi</italic> and its direct anticancer effect in cultured human tumor cells</article-title><source>Bull Exp Biol Med</source><year>2003</year><volume>135</volume><issue>1</issue><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1023/a:1023466517225</pub-id><pub-id pub-id-type="pmid">12717523</pub-id>
</element-citation><mixed-citation id="mc-CR114" publication-type="journal">Sheklakova LA, Kallinikova VD, Karpenko LP (2003) Genetic heterogeneity of <italic>Trypanosoma cruzi</italic> and its direct anticancer effect in cultured human tumor cells. Bull Exp Biol Med 135(1):89&#x02013;92. 10.1023/a:1023466517225<pub-id pub-id-type="pmid">12717523</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name><surname>Kallinikova</surname><given-names>VD</given-names></name><name><surname>Batmonkh</surname><given-names>T</given-names></name><name><surname>Kosobokova</surname><given-names>EN</given-names></name><name><surname>Pakhorukova</surname><given-names>LV</given-names></name><name><surname>Ogloblina</surname><given-names>TA</given-names></name><name><surname>Kravtsov</surname><given-names>EG</given-names></name><etal/></person-group><article-title>Antibodies against <italic>Trypanosoma cruzi</italic> in intact mice and their oncoprotective effect</article-title><source>Med Parazitol</source><year>2008</year><volume>1</volume><fpage>11</fpage><lpage>15</lpage></element-citation><mixed-citation id="mc-CR115" publication-type="journal">Kallinikova VD, Batmonkh T, Kosobokova EN, Pakhorukova LV, Ogloblina TA, Kravtsov EG et al (2008) Antibodies against <italic>Trypanosoma cruzi</italic> in intact mice and their oncoprotective effect. Med Parazitol 1:11&#x02013;15</mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Eligio Garc&#x000ed;a</surname><given-names>L</given-names></name><name><surname>Cris&#x000f3;stomo V&#x000e1;zquez</surname><given-names>MDP</given-names></name><name><surname>Maravelez Acosta</surname><given-names>VA</given-names></name><name><surname>Soria Guerrero</surname><given-names>M</given-names></name><name><surname>Cort&#x000e9;s Campos</surname><given-names>A</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>CE</given-names></name></person-group><article-title><italic>Trypanosoma cruzi</italic> antigenic proteins shared with acute lymphoblastic leukemia and neuroblastoma</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><issue>11</issue><fpage>1421</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.3390/ph15111421</pub-id><pub-id pub-id-type="pmid">36422551</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Eligio Garc&#x000ed;a L, Cris&#x000f3;stomo V&#x000e1;zquez MDP, Maravelez Acosta VA, Soria Guerrero M, Cort&#x000e9;s Campos A, Jim&#x000e9;nez CE (2022) <italic>Trypanosoma cruzi</italic> antigenic proteins shared with acute lymphoblastic leukemia and neuroblastoma. Pharmaceuticals 15(11):1421&#x02013;1431. 10.3390/ph15111421<pub-id pub-id-type="pmid">36422551</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name></person-group><article-title>The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer</article-title><source>Front Oncol</source><year>2023</year><volume>13</volume><fpage>1333839</fpage><lpage>1333858</lpage><pub-id pub-id-type="doi">10.3389/fonc.2023.1333839</pub-id><pub-id pub-id-type="pmid">38273859</pub-id>
</element-citation><mixed-citation id="mc-CR117" publication-type="journal">Zheng J, Hao H (2023) The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. Front Oncol 13:1333839&#x02013;1333858. 10.3389/fonc.2023.1333839<pub-id pub-id-type="pmid">38273859</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name><surname>Zahavi</surname><given-names>D</given-names></name><name><surname>Weiner</surname><given-names>L</given-names></name></person-group><article-title>Monoclonal antibodies in cancer therapy</article-title><source>Antibodies</source><year>2020</year><volume>9</volume><issue>3</issue><fpage>34</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.3390/antib9030034</pub-id><pub-id pub-id-type="pmid">32698317</pub-id>
</element-citation><mixed-citation id="mc-CR118" publication-type="journal">Zahavi D, Weiner L (2020) Monoclonal antibodies in cancer therapy. Antibodies 9(3):34&#x02013;54. 10.3390/antib9030034<pub-id pub-id-type="pmid">32698317</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>